WO1990004652A1 - Dna sequencing by multiple mixed oligonucleotide probes - Google Patents
Dna sequencing by multiple mixed oligonucleotide probes Download PDFInfo
- Publication number
- WO1990004652A1 WO1990004652A1 PCT/US1989/004741 US8904741W WO9004652A1 WO 1990004652 A1 WO1990004652 A1 WO 1990004652A1 US 8904741 W US8904741 W US 8904741W WO 9004652 A1 WO9004652 A1 WO 9004652A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- probe
- probes
- fixed
- nucleic acid
- sequence
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
- C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/808—Automated or kit
Definitions
- Native DNA consists of two linear polymers, or strands of nucleotides. Each strand is a chain of nucleosides linked b y phosphodiester bonds. The two strands ar-e held together in an antiparallel orientation by hydrogen bonds between complementary bases of the nucleotides of the two strands: deoxyadenosine (A) pairs with thymidine (T) and deoxyguanosine ( G ) pairs with deoxycytidine (C).
- A deoxyadenosine
- T thymidine
- G deoxyguanosine
- the dideoxy chain termination method e.g. S anger et al, Proc ⁇ Natl. Acad. Sci.., Vol. 74, pgs. 5463-5467 ( 1977); and the chemical degradation method, e.g. Maxa et al, Proc ⁇ N ati ⁇ A cacL Sc_i ⁇ , Vol. 74, pgs.560-564 (1977 ) .
- the chain termination method has been improved in several ways, an d serves as the basis for all currently available automated DNA sequencing machines, e.g. Sanger et al, J ⁇ ol. Biol., Vol. 143, pgs.
- Non-automated sequencing can accommodate a DNA chain of up to about 500 bases under optimal conditions, and automated sequencing can accommodate a chain of up to about 300 bases under optimal conditions, Bankier et al, Meth. Enzymol., Vol. 155, pgs. 51-93 (1987); Roberts, Science, Vol. 238, pgs. 271-273 (1987); and Smith et al. Biotechnology, Vol. 5, pgs. 933-939 (1987).
- nucleic acid hybridization has also been a crucial element of many techniques in molecular biology, e.g. Hames et al, eds.. Nucleic Acid Hybridization: A Practical Approach (IRL Press, Washington, D.C., 1985).
- hybridization techniques have been used to select rare cDNA or genomic clones from large libraries by way of mixed oligonucleotide probes, e.g. Wallace et al, Nucleic Acids Research, Vol. 6, pgs. 3543-3557 (1979), or by way of interspecies probes, e.g. Gray et al, Proc. Natl. Acad. Sci., Vol. 80, pgs.
- Nucleic acid hybridization has also been used to determine the degree of homology between sequences, e.g. Kafatos et al, Nucleic Acids Research, Vol. 7, pgs. 1541-1552 (1979), and to detect consensus sequences, e.g. Oliphant et al, Meth. Enzymol., Vol. 155, pgs. 568-582 (1987). Implicit to all of these applications is the notion that the known probe sequences contain information about the unknown target sequences. This notion apparently has never been exploited to obtain detailed sequence information about a target nucleic acid.
- the invention is directed to a method for determining the nucleotide sequence of a DNA or an RNA molecule using multiple mixed oligonucleotide probes. Sequence information is obtained by carrying out a series of hybridizations whose results provide for each probe the number of times the complement of the probe's sequence occurs in the RNA or DNA whose sequence is to be determined. The nucleotide sequence of the RNA or DNA is reconstructed from this information and from a knowledge of the probes' sequences. The nucleic acid whose sequence is to be determined is referred to herein as the target sequence.
- the mixed oligonucleotide probes of the invention are selected from a set whose members' sequences include every possible complementary sequence to subsequences of a predetermined length within the target sequence.
- the series of hybridizations are separately carried out such that one or more of the probes selected from the set are combined with known quantities of the target sequence, e.g. on a nitrocellulose filter, or like substrate, under conditions which substantially allow only perfectly matched probe sequences to hybridize with the target sequence.
- Probe sequences having mismatched bases are substantially removed, e.g. by washing, and the quantity of perfectly matched probe remaining hybridized to the target sequence is determined.
- the set of probes comprises four subsets.
- Each of the four subsets contains probes representing every possible sequence, with respect to the size of the probe (which is predetermined), of only one of the four bases.
- the first subset can contain probes where every possible sequence of G is represented; the second subset can contain probes where every possible sequence of T is represented; and so on for C and A. If the probes were each 8 bases long, a member probe of the adenosine subset can be represented as follows:
- the above probe has a multiplicity, or degeneracy, of 1x1x3x3x1x3x1, or 81.
- A represents deoxyadenosine
- 0 represents the absence of deoxyadenosine.
- base analogs are employed in the oligonucleotide probes whose base pairing characteristics permit one to reduce the multiplicity of the probe.
- deoxyinosine (I) forms nearly equally strong base pairs with A and C, but forms only a weak or destabilizing base pair with either G or T
- deoxyinosine can replace G and T in the probe, Martin et al. Nucleic Acids Research, Vol. 13, pgs. 8927-8938 (1985).
- a probe equivalent to that of Formula I, but which has a much lower multiplicity i.e. only 16
- multiplicity i.e. only 16
- base analogs are preferred which form strong base pairs (i.e., comparable in binding energy to the natural base pairs) with two or three of the four natural bases, and a weak or destabilizing base pair with the complement of a fixed base (defined below). Such base analogs are referred to herein as degeneracy-reducing analogs.
- the probes will be fixed at a predetermined number of positions with known bases (not necessarily of the same kind), e.g. as the A in Formula I, and the remaining positions will each be filled by a base randomly selected from a predetermined set, e.g. T, G, and C as in Formula I, or I and C as in Formula II.
- the positions in a probe which are non- degenerate in their base pairing, i.e. have only a single natural base, are referred to herein as fixed positions.
- the bases occupying fixed positions are referred to herein as fixed bases.
- the fixed bases in the probes of Formulas I and II are deoxyadenosine at positions one, two, five, and eight with respect to the 3' end of the probe.
- sets and/or subsets of the invention each contain at least one probe having a sequence of fixed and non- fixed positions equivalent to that of each permutation of a plurality of fixed and non-fixed positions less than or equal to the length of the probe. That is, an important feature of the invention is that the probes collectively contain •subsequences (up to the total length of the probe) which correspond to every possible permutation of fixed and non- fixed positions of each of a plurality of combinations of fixed and non-fixed positions, the plurality including combinations containing from zero to all fixed positions.
- probes of the invention that consist of 8-mer probes whose fixed positions contain only deoxyadenosine and whose initial (i.e., 3'-most) position is fixed.
- the probes of Formulas I and II are members of such a subset.
- the target sequence contains one or more regions of known sequence, these regions being referred to herein as known sequence regions. More preferably, the target sequence contains a first and a second known sequence region, the first and second known sequence regions being positioned on opposite ends of the region of the target sequence containing the unknown, sequence of nucleotides. This unknown sequence of nucleotides is referred to herein as the unknown sequence region. Most preferably, the first and second known sequence regions are at least the length of the longest probe sequence.
- Mixed oligonucleotide probes for the invention are preferably synthesized using an automated DNA synthesizer, e.g. Applied Biosystems (Foster City, CA) models 381A or 38OB, or like instrument.
- an automated DNA synthesizer e.g. Applied Biosystems (Foster City, CA) models 381A or 38OB, or like instrument.
- Applied Biosystems Foster City, CA
- mixtures of the appropriate nucleotide precursors are reacted with the growing oligonucleotide chain so that oligonucleotides having different different bases at that position are synthesized simultaneously, e.g. as disclosed by Wallace et al, Nucleic Acids Research, Vol. 6, pgs.3543-3557 (1979), and Oliphant et al, Meth. Enzymol., Vol. 155, pgs. 568-582 (1987).
- the probes may be synthesized by way of any of the available chemistries, e.g. phosphite triester, Beaucage et al. Tetrahedron Letters, Vol. 22, pgs. 1859-1862 (1981); Caruthers et al, U.S. patents 4,415,723, 4,458,066, and 4,500,707; phosphotriester, Itakura, U.S. patent 4,401,796; hydrogen phosphonate, e.g. Froehler et al, Nucleic Acids Research, Vol. 14, pgs. 5399-5407 (1986); or the like.
- phosphite triester Beaucage et al. Tetrahedron Letters, Vol. 22, pgs. 1859-1862 (1981)
- Caruthers et al U.S. patents 4,415,723, 4,458,066, and 4,500,707
- phosphotriester Itakura, U.
- the oligonucleotides are purified for labeling by well known techniques, usually HPLC or gel electrophoresis, e.g. Applied Biosystems DNA Synthesizer Users Bulletin, Issue No. 13-Revised (April 1, 1987).
- probe multiplicity permits hybridization with reasonable Cot values (longer probes are more degenerate than shorter probes, and require higher Cot values for hybridization, the converse is true of shorter probes); (4) the practicality of carrying out separate hybridizations for each type of probe (longer probes give rise to larger sets of probes, as described above); and (5) the tractability
- degeneracy-reducing analogs are employed at the non-fixed positions of the probes to reduce probe multiplicity, or degeneracy.
- Many synthetic and natural nucleoside and nucleotide analogs are available for this purpose, e.g. Scheit, Nucleotide Analogs (John Wiley & Sons, New York, 1980).
- degeneracy-reducing analogs include deoxyinosine for use in cytosine or adenosine probes to replace G and T at non-fixed positions, 2-aminopurine for use in cytosine or guanosine probes to replace A and T at non-fixed positions, and N 4 - methoxydeoxycytidine, N - aminodeoxycytidine, or 5-fluorodeoxyuridine for use in adenosine or guanosine probes to replace T and C.
- deoxyinosine for use in cytosine or adenosine probes to replace G and T at non-fixed positions
- 2-aminopurine for use in cytosine or guanosine probes to replace A and T at non-fixed positions
- N 4 - methoxydeoxycytidine, N - aminodeoxycytidine, or 5-fluorodeoxyuridine for use in adenosine or guanosine probes to replace T and
- N 4 -methoxycytidine and its incorporation into oligonucleotide probes The synthesis of N 4 -methoxycytidine and its incorporation into oligonucleotide probes is disclosed by Anand et al. Nucleic Acids Research, Vol. 15, pgs. 8167-8176 (1987). The synthesis of 2-aminopurine and its incorporation into oligonucleotide probes is disclosed by Eritja et al. Nucleic Acids Research, Vol. 14, pgs. 5869-5884 (1986). The synthesis of 5-fluorodeoxyuridine and its incorporation into oligonucleotide probes is disclosed by Habener et al, Proc. Natl. Acad. Sci., Vol. 85, pgs. 1735-1739 (1988). And the preparation of N 4 -aminodeoxycytidine is disclosed by Negishi et al. Nucleic Acids Research, Vol. 11,
- Nucleoside analogs are also employed in the invention to reduce the differences in binding energies between the various complementary bases.
- 2-aminoadenine can replace thymine in either the probe or target sequences to reduce the binding energy differences between A-T nucleoside pairs and G-C nucleoside pairs, e.g. Kirnos et al (cited above), Choilet et al (cited above), and Cheong et al. Nucleic Acids Research, Vol. 16, pgs. 5115-5122 (1988). Procedures for synthesizing oligonucleotides containing 2-aminoadenine are disclosed by Choilet et al (cited above); Gaffney et al. Tetrahedron, Vol. 40, pgs.
- the oligonucleotides of the invention can be labeled in a variety of ways to form probes, including the direct or indirect attachment of radioactive moieties, fluorescent moieties, electron dense moieties, and the like. It is only important that each sequence within a probe be capable of generating a signal of the same magnitude, so that quantitative measurements of probe number can be made.
- There are several means available for derivatizing oligonucleotides with reactive functionalities which, permit the addition of a label e.g. Connolly, Nulceic Acids Research, Vol 15, pgs. 3131-3139 (1987); Gibson et al. Nucleic Acids Research, Vol. 15, pgs. 6455-6467 (1987); Spoat et al. Nucleic Acids Research, Vol. 15, pgs. 4837-4848 (1987); and Mathews et al. Anal. Biochem., Vol. 169, pgs. 1-25 (1988).
- the oligonucleotides of the invention are radioactively labeled with - 2 P using standard protocols, e.g. Maxim and Gilbert, Meth. Enzymol., Vol. 65, pgs. 499-560 (1980).
- 32 P-labeled probes of the invention are preferably applied to targent DNAs anchored to nitrocellulose, nylon, or the like, at a concentration in the range of about 1-10 ng/ml, and more preferably, in the range of about 1-5 ng/ml.
- the specific activities of the probe are preferably in the range of about 1-5 X 10° cpm/ml.
- the hybridizations of the probes to the target sequence are carried out in a manner which allows mismatched probe sequences and nonspecifically bound probe sequences to be separated from the duplexes formed between the perfectly matched probe sequences and the target sequence. Usually the separation is carried out by a washing step.
- the first step in the hybridizations is to anchor the target sequence so that washes and other treatments can take place with minimal loss of the target sequences.
- the method selected for anchoring the target sequence depends on several factors, including the length of the target, the method used to prepare copies of the target, and the like.
- the target sequence is anchored by attaching it to a substrate or solid phase support, such as nitrocellulose, nylon-66, or the like, or such as derivatized microsphere ⁇ , e.g. Kremsky et al. Nucleic Acids Research, Vol. 15, pgs.2891- 2909 (1987).
- a substrate or solid phase support such as nitrocellulose, nylon-66, or the like, or such as derivatized microsphere ⁇ , e.g. Kremsky et al. Nucleic Acids Research, Vol. 15, pgs.2891- 2909 (1987).
- a known quantity of single or double stranded copies of the target sequence is anchored to the substrate, or solid phase support.
- known quantity means amounts from which integral numbers of perfectly matched probes can be determined. In some embodiments this means known gram or molar quantities of the target sequence. In other embodiments, it can mean equal amounts of target sequence on the plurality of solid phase supports, so that signals corresponding to integral numbers of probes can be discerned by comparing signals from the plurality of supports, or by comparing signals to specially provided standards.
- the anchoring means is loaded to capacity with the target sequence so that maximal signals are produced after hybridization.
- the target sequence can be prepared in double stranded form, denatured, and then applied to the anchoring means, which is preferably a solid phase support, such as nitrocellulose, GeneScreen, or the like.
- the anchoring means which is preferably a solid phase support, such as nitrocellulose, GeneScreen, or the like.
- the target sequence is prepared in double stranded form, it is preferably excised from its cloning vector with one or more endonucleases which leave blunt ended fragments, e.g. Eco RV,A.u I, Bal I, Dra I, Nae I, Sma I, or the like.
- both the coding, or sense, strand and the noncoding, or antisense, strand are sequenced simultaneously. Because of sequence complementarity, the reconstruction problem is no more difficult than in the single stranded case.
- Suitable vectors for preparing double stranded target sequences are those of the pUC series, e.g. Yanisch-Perron et al, Gene, Vol. 33, pgs. 103-119 (1985). These vectors are readily modified by adding unique restriction sites to their polylinker regions. The new unique restriction sites are selected from restriction endonucleases that leave flush-ended fragments after digestion. For example, chemically synthesized fragments containing such sites can be inserted into the Hind III and Eco RI sites of pUC18 or pUC19. For these vectors such sites include Bal I, Eco RV, Hpa I, -Nae I, Nru I, Stu I, Sna BI, and Xca I.
- the precursor of the target sequence i.e. the unknown sequence region
- a preexisting polylinker site e.g. Bam HI
- the vector can be amplified and isolated
- the target sequence can be excised via the restriction endonucleases that leave flush-ended fragments.
- the fragments of the polylinker region excised along with the unknown sequence region then become the known sequence regions of the target sequence.
- the preferred method of anchoring DNA to nitrocellulose filters is essentially that described by Kafatos et al (cited above). Up to about 1 ug of target sequence is applied per square millimeter of the filter. Before application the DNA is denatured, preferably in 0.3 to 0.4 N NaOH for about 10 minutes, after which it is chilled with an equal volume of cold water, or optionally cold 2 M ammonium acetate, to a concentration of about 16 ug/ml. Known quantities of the denatured target are spotted onto the filter by carefully controlling the volume of liquid deposited.
- the filter can optionally be rinsed through with a drop of 1 M ammonium acetate containing about .02-0.2 N NaOH, pH 7.8-9.0. Filters may also be washed with 4xSSC (defined below), e.g. about 200 ml.
- 4xSSC defined below
- the filters are air dried, shaken in 2x Denhardt's solution (defined below) for at least 1 hour, drained and air dried again, and baked under vacuum at 80° C for about 2 hours.
- Hybridization of the probes to the target sequence usually comprises three steps: a prehybridization treatment, application of the probe, and washing.
- the purpose of the prehybridization treatment is to reduce nonspecific binding of the probe to the anchoring means and non-target nucleic acids. This is usually accomplished by blocking potential nonspecific binding sites with blocking agents such as proteins, e.g. serum albumin (a major ingredient of Denhardt's solution).
- prehybridization treatment can comprise treatment with 5-10x Denhardt's solution, with 2-6x SSC preferably containing a mild detergent, e.g.
- SDS sodium dodecylsulfate
- Denhardt's solution disclosed in Biochem. Biophys. Res. Commun., Vol. 23, pgs. 641-645 (1966), consists at lOx concentration of 0.2% bovine serum albumin, 0.2% polyvinylpyrolidone, and 0.2% Ficoll.
- SSC another standard reagent in the hybridization art, consists at lx of 0.15 M NaCl, 0.015 M sodium citrate, at pH 7.0. Preferred treatment times, temperatures, and formulations may vary with the particular embodiment.
- the probe is applied to the anchored DNA at a concentration in the range of about 1-10 ng/ml in a solution substantially the same as the prehybridization solution, e.g. 5-10x Denhardt's solution with 2-6x SSC and a mild detergent, e.g. 0.5% SDS. More preferably, the probe concentration is in the range of about 1-5 ng/ml.
- the hybridization is carried out at a temperature 10-20° C below the expected 50% dissociation temperatue, TJ, between the probe and the target. That is, a temperature is selected at which a high proportion, e.g. greater than 80-90%, of all the perfectly matched probes form stable duplexes.
- hybridization temperature is in the range of about 10-18° C.
- Hybridization times are preferably in the range of about 3-16 hours. Different hybridization times may be selected for probes of different degrees of degeneracy, because the effective consentrations of particular sequences within a highly degenerate probe, e.g. 0A000000, are considerably less than those of particular sequences in a low degeneracy probe, e.g. AAAOAAAA. Thus, higher Cot values (which usually means longer hybridization times) may be required for more degenerate probes to attain a sufficient degree of binding of perfectly matched sequences.
- a single hybridization time is selected for all probes which is determined by the hybridization kinetics of the most degenerate probe.
- Probe degeneracy becomes important when relative signals are compared after autoradiography. Probes having higher degeneracy will produce lower signals than probes of lower degeneracy. Therefore, relative signals should only be compared among autoradiographs associated with probes of equivalent degeneracy. Signal comparisons are aided by the simultaneous running of positive and negative controls for each probe, or at least for each degeneracy class. Removing nonspecifically bound and mismatched probe sequences by washing is an important aspect of the invention.
- Temperatures and wash times are selected which permit the removal of a maximum amount of nonspecifically bound and mismatched probe sequences, while at the same time permit the retention of a maximum number of probe sequences forming perfectly matched duplexes with the target.
- the length and base composition of the probe are two important factors in determining the appropriate wash temperature. For probe lengths in the preferred range of 7-11 bases, the difference in duplex stability between perfectly matched and mismatched probe sequences is quite large, the respective T ⁇ 's differing by perhaps as much as 10° C, or more. Thus, it is not difficult to preferentially remove mismatches by adjusting wash temperature. On the other hand, composition differences, e.g.
- hybridization conditions and/or nucleotide analogs are selected which minimize the difference in binding energies of the various base pairs, in order to minimize sequence-specific differences in probe binding.
- minimization is preferable because it increases the sensitivity with which perfectly matched probes can be detected. Sensitivity is increased because such minimization makes the transition from probe/target duplexes to single stranded probe and single stranded target much sharper when temperature is increased, i.e. the probe/target T m is less broad.
- the differences in binding energy between G-C pairs and A-T pairs is reduced, e.g. Wood et al, Proc. Natl. Acad.
- a preferred wash procedure for 8-mer probes comprises washing the filters three times for about 15 minutes in 6x SSC containing 0.5% SDS at a temperature in the range of about 10-12° C, followed by one or two rinses with 3.0 M Me 4 NCl, 50 mM Tris-HCl, pH 8.0, 0.5% SDS, at a temperature in the range of about 10-12° C, followed by a 1.5- 2.5 minute wash in 3.0 M Me 4 NCl, 50 mM Tris-HCl, pH 8.0, 0.5% SDS, at a temperature in the range of about 24-28° C.
- the procedure is substantially the same, except that the final wash temperature is preferably in the range of about 26-30°C.
- quantitative measurements of bound probe are carried out using standard techniques, e.g. for radiolabelled probes, autoradiography or scintillation counting can be used.
- Figure 1 The general nature of the reconstruction problem is illustrated by the example of Figure 1, in which four subsets of 4-mer probes are used to analyze the sequence of the 21- mer, CGAATGGAACTACCGTAACCT.
- Figure 1 On the left of Figure 1 is a list of 4-mer probes having every possible permutation of fixed and non-fixed positions with respect to deoxyadenosine, deoxycytosine, deoxyguanosine, and thymidine, respectively, for the following combinations of fixed bases and non-fixed bases: 1 fixed and 3 non-fixed, 2 fixed and 2 non-fixed, 3 fixed and 1 non-fixed, and 4 fixed and 0 non-fixed.
- the list contains at least one probe having a sequence of fixed and non-fixed positions with respect to A, C, G, and T equivalent to every possible permutation of A's and non-fixed positions, C's and non-fixed positions, G's and non-fixed positions, and T's and non-fixed positions, respectively.
- the data obtained by separately hybridizing the 60 probes to the 21-mer are listed under the column, "Perfect Matches.”
- the data represent the number of each probe type having perfect complementarity with a four base subsequence of the 21- mer. Under the 21-mer sequence itself the probes are positioned along the sequence where perfect complementarity occurs.
- the objective of a reconstruction algorithm is to determine the positions of enough probes so that the target sequence can be reconstructed.
- the reconstruction problem can be approached in many ways.
- the problem is related to the traveling salesman problem in that it involves finding a permutation of objects which is in some sense optimal.
- There is an extensive literature on such combinatorial problems which provides guidance in formulating the best approach for a particular embodiment, e.g. Lawler et al, eds., The Traveling Salesman Problem: A Guided Tour of Combinatoria1 Optimization (John Wiley & Sons, New York, 1985); Kirkpatrick, J. Stat. Phys., Vol. 34, pgs. 975-986 (1984); Held and Karp, J. Soc. Indust. Appl. Math., Vol.10, pgs.196-210 (1962); and Lin and Kernighan, Oper.
- the target sequence include one or more known sequence regions.
- a first known sequence region is located at one end of the target sequence and a second known sequence region is located at the other end of the target sequence.
- the presence of the two known sequence regions permits the construction of a simplified and efficient reconstruction algorithm.
- the reconstruction problem is a problem of finding an ordering of overlapping probe sequences which corresponds to the target sequence.
- the known sequence regions define the starting and ending probes sequences in a reconstruction.
- the intervening unknown sequence region can be reconstructed from the remaining probe sequences by requiring that each successively selected probe properly overlap the previously selected probe sequence.
- Figure 2 is a flow chart of such an algorithm.
- two sets of numbers are defined by the nucleotide sequences of the first and second known sequence regions. These sets are referred to as the initial left register and the initial right register 2, respectively.
- the size of the registers depends on the length of the probes employed. Usually the registers have L-l elements, or entries, where L is the length of the probe.
- the algorithm compares the entries of the register with every FFP and FIP probe that forms a perfect match with the target sequence, 4. The comparison is between bases 2 through L of the selected probe and the numbers (or entries) 1 through L-l of the right register.
- base at position 2 is compared to the entry at position 1 of the right register
- base at position 3 is compared to the entry at position 2 of the right register
- the entries of the registers are determined by the bases of the first and second known sequence regions. If the comparison results in proper overlap in each of the L-l positions, then the current contents of the register are loaded into a new right register and then the entries of the new right register are shifted to the right one position. That is, entry 1 of the new right register is moved to position 2, entry 2 is moved to position 3, and so on. Entry L-l is discarded, and the fixed base at the initial position of the probe (or some representation of it) is loaded into position 1.
- an FFP probe must be found that properly overlaps the register and the initial fixed base of the selected FIP probe (unless of course the FIP probe is also an FFP probe) 8.
- selections i.e. 4 and 8
- the selected probe(s) are removed from the data set.
- the new right register is saved along with and associated set of properly overlapping FIP probes whose selections led to the current register, and an associated set of properly overlapping FFP probes.
- one or more left registers are formed, 16 and 18, by extending preexisting left registers in substantially the same way as the right registers, excepts that FFP probes are selected first and positions 1-L of the FFP probe are compared to entries 1-L of the left register.
- the FIP and FFP probes are selected from the probes remaining in the data set. That is, any probes previously selected to "extend" the right or left registers cannot be selected. This also holds for right registers formed in successive iterations after the first.
- pairs of right and left registers are formed, and associated with each pair are four sets of probes, 20: (i) the set of FIP probes selected to extend the right register, (ii) the set of FFP probes selected to properly overlap the right register and FIP probe, (iii) the set of FFP probes selected to extend the left register, and (iv) the set of FIP probes selected to properly overlap the left register and FFP probe.
- M i+1 suc *h pairs a* n d associated sets are formed.
- the comparisons between probe and register positions are carried out as follows.
- the register entries are always the bases A, C, G, or T (or some representation thereof).
- the probe positions are always occupied by a base or the absence of a base.
- probes can be represented by the notation, for example, AOAAOOOA.
- the 0's represent in this case represent either C, G, T, or a degeneracy-reducing analog thereof. In other words, the 0's represent "not A's".
- the comparisons entail the determination of the truth value of a base (from the register) and a base or a negative of a base (from the probe being compared).
- each of the MJ pairs of registers are compared to probes of their respective data sets, generating in turn, a set of M j _ + pairs of registers.
- the data set is reduced in size by two or more probes, and the respective canditate sequences are increased in size by one base each.
- the register and its associated sets are discarded 6-14. The algorithm halts when every probe in the data sets have been used (i.e., sorted into one of the four associated sets).
- the same process of repeated rounds of comparisons can be carried out starting with the initial left register and set of probes that have fixed final positions and a perfect match with the target sequence 10-16.
- entries 1 through L-l of the initial left register are compared with probe positions 1 through L-l, respectively, and successive registers, R- after the jth round of comparisons, are generated by shifting current entries to the left and entering the final fixed base of the properly overlapping probe to position L-l of the new register.
- additional candidate sequences are generated, and are compared to the ones previously generated. Only ones that occur in both sets are retained 18. Further eliminations are possible by requiring that all of the remaining non-fixed final and non-fixed initial position probes find properly overlapping positions within each of the candidates 20.
- the algorithm is implemented on a computer with parallel processing capabilities.
- the algoithm of appendix I can be loaded onto each of the nodes of a hypercube parallel processor, e.g. a 1024 node NCUBE/ten computer (Ncube Corp., Beaverton, Oregon).
- Example I Sequence • Determination of the 119 Basepair Sca-Xmn Fragment of pUC19 with 8-mer Probes
- a 119 basepair double stranded DNA is obtained by Xmn I and Sea I restriction endonuclease digestion of the pUC19 plasmid, described by Yanisch-Perro et al. Gene, Vol. 33, pgs. 103-119 (1985), and widely available commercially, e.g. Bethesda Research Laboratories (Gaithersburg, MD). Large scale isolation of pUC19 can be carried out by standard procedures, e.g.
- pUC19 is purchased commercially as needed, e.g. from Bethesda Research Laboratories.
- 1 mg pUC19 DNA is precipitated with 95% ethanol, dried, and resuspended in 1 ml of Sca-Xmn restriction buffer (e.g., 50 mM NaCl, 10 mM Tris-HCl (pH 7.8), 10 mM MgCl 2 , lOmM 2- mercaptoethanol, 100 ug bovine serum albumin) for about 2.0 hours at 37°C.
- Sca-Xmn restriction buffer e.g., 50 mM NaCl, 10 mM Tris-HCl (pH 7.8), 10 mM MgCl 2 , lOmM 2- mercaptoethanol, 100 ug bovine serum albumin
- the restriction buffer is mixed with xylene cyanol and loaded onto a 8 percent polyacrylamide gel for electrophoresis. The band containing the 119 basepair fragment is excised, and the DNA eluted as described by Maniatis et al, page 178 (cited
- the fragments are resuspended at 1 ng/100 ul of 0.2 N NaOH for 10 minutes, chilled, and mixed with an equal volume of lOxSSC (1.5 M sodium chloride and 0.15 M sodium citrate). 100 ul samples of this fragment solution are pipetted into the wells of slot-blotting apparatus, e.g. eleven 72-well Minifold II micro-sample filtration manifolds, available from Schleicher and Scheull, Keene, NH), each apparatus holding a GeneScreen membrane that had been previously wetted for 15- 20 minutes in lxSSC. After 2 hours, the solution is gently sucked through the membranes, washed with 2xSSC, and allowed to dry.
- slot-blotting apparatus e.g. eleven 72-well Minifold II micro-sample filtration manifolds, available from Schleicher and Scheull, Keene, NH
- the membranes are baked at 80°C for 2-4 hours. Before application of probe, the membranes are treated with prehybridization mixture (lOx Denhardt's with 0.5% SDS for 1 hour at 60°C, followed by washing with 2xSSC).
- prehybridization mixture lOx Denhardt's with 0.5% SDS for 1 hour at 60°C, followed by washing with 2xSSC.
- Numbers of perfectly matched probes are determined by comparing the relative signal strengths of probes having the same degree of degeneracy. Also, because a double stranded target sequence is used, the values for probe number used in the reconstruction algorithm are the average of the signal for each probe type and its complement (with respect to the fixed bases).
- the sequence is reconstructed from the probe number data by program RC0N8, whose source code is listed in the Appendix. RC0N8 assumes that the eight base sequences on each end of the target sequence are known sequence regions. The program returns the noncoding sequence listed in a 3*-5' orientation from left to right.
- Example II Sequence Determination of the 323 Basepair Pvu II Fragment of pUC19 Using 9-mer Probes
- a 323 basepair double stranded DNA is one of two fragments obtained by Pvu II digestion of pUC19. The same procedure is followed as described in Example I for preparing the 323 basepair Pvu II fragments, denaturing them, and anchoring them to GeneScreen substrates. Pre-hybridization, hybridization, and wash protocols are the same, except that the final high temperature wash is carried out at 28-29°C.
- Probes are synthesized and labeled as in Example I. 1556 probes are employed. A probe is prepared for each 9-mer sequence having a fixed base at the initial or final position (i.e. 389 each for A, C, G, and T probes). As in Example I, probes of the form 100000000 and 000000001 are replaced by three probes having different types of fixed bases, e.g. OOOOOOOOT is replaced by AOOOOOOOT, COOOOOOOT, and G0000000T.
- the sequence of the Pvu fragment is reconstructed with a modified version of the program of Appendix I which specifically accommodates 9-mer probe data. Like the 8-mer version, the program assumes that the nine base sequences on each end of the target sequence are known sequence regions.
- Figure 1 illustrates the general problem of sequence reconstruction by showing how a 21-mer sequence can be reconstructed by four subsets of 4-mer probes.
- Figure 2 is a flow chart diagrammatically illustrating a preferred reconstruction algorithm.
- c NPX is the number of probes in the data having c an initial (3") fixed base.
- 3000 continue 5000 end c c subroutine left(ii,w,f, jsave,ksave) implicit integer*2 (a-z) dimension rl(xx,120) ,r2(xx,120) ,ll(xx,120) ,12(xx,120) dimension dr2(xx,120) ,dll(xx,120) ,dl2(xx,120) ,drlnum(xx) dimension dr2num(xx) ,dllnum(xx) ,dl2num(xx) ,pset(240,2) dimension pnum ⁇ (4,259,8 ) ,rregl(xx,7) ,rreg2(xx,7) dimension lreg2(xx,7) ,lregl(x ,7) dimension tab(4,-4:4) ,drl(xx,120 ) character*1 pseq ⁇ (4,25 , ⁇ ) common rl,r2,11,12,dr1,dr2,d
Abstract
A method is provided for sequencing nucleic acids without the need to separate similarly sized DNAs or RNAs by gel electrophoresis. The method relies on the separate hybridization of multiple mixed oligonucleotide probes to a target sequence. The mixed oligonucleotide probes comprise sequences of fixed and non-fixed bases corresponding to every possible permutation of fixed and non-fixed bases less than or equal to the length of the probes. For each probe, the hybridizations provide the number of times the probe's particular sequence of fixed bases appears in the target sequence. The target sequence is then mathematically reconstructed from this data and a knowledge of the probe sequences.
Description
DNA SEQUENCING BY MULTIPLE MIXED OLIGONUCLEOTIDE PROBES
Background
The ability to determine DNA sequences is crucial for understanding the function and control of genes and for applying many of the basic techniques of molecular biology. Native DNA consists of two linear polymers, or strands of nucleotides. Each strand is a chain of nucleosides linked by phosphodiester bonds. The two strands ar-e held together in an antiparallel orientation by hydrogen bonds between complementary bases of the nucleotides of the two strands: deoxyadenosine (A) pairs with thymidine (T) and deoxyguanosine (G) pairs with deoxycytidine (C).
Presently there- are two basic approaches to DNA sequence determination: the dideoxy chain termination method, e.g. Sanger et al, Proc^Natl. Acad. Sci.., Vol. 74, pgs. 5463-5467 (1977); and the chemical degradation method, e.g. Maxa et al, Proc^ Nati^ AcacL Sc_i^, Vol. 74, pgs.560-564 (1977). The chain termination method has been improved in several ways, and serves as the basis for all currently available automated DNA sequencing machines, e.g. Sanger et al, J^ ol. Biol., Vol. 143, pgs. 161-178 (1980); Smith et al, Nucleic Acids Research, Vol. 13, pgs. 2399-2412 (1985); Smith et al, Nature, Vol. 321, pgs. 674-679 (1987); Prober et al, Science, Vol. 238, pgs. 336-341 (1987), Section II, Meth. Enzymol., Vol. 155, pgs. 51-334 (1987),and Church et al, Science, Vol 240, pgs. 185-188 (1988).
Both the chain termination and chemical degradation methods require the generation of one or more sets -of labeled DNA fragments, each having a common origin and each terminating with a known base. The set or sets of fragments must then be separated by size to obtain sequence information. In both methods, the DNA fragments are separated by high resolution gel electrophoresis. Unfortunately, this step severely limits the size of the DNA chain that can be sequenced at one time. Non-automated sequencing can
accommodate a DNA chain of up to about 500 bases under optimal conditions, and automated sequencing can accommodate a chain of up to about 300 bases under optimal conditions, Bankier et al, Meth. Enzymol., Vol. 155, pgs. 51-93 (1987); Roberts, Science, Vol. 238, pgs. 271-273 (1987); and Smith et al. Biotechnology, Vol. 5, pgs. 933-939 (1987).
This limitation represents a major bottleneck for many important medical, scientific, and industrial projects aimed at unraveling the molecular structure of large regions of plant or animal genomes, such as the project to sequence all or major portions of the human genome, Smith et al. Biotechnology (cited above).
In addition to DNA sequencing, nucleic acid hybridization has also been a crucial element of many techniques in molecular biology, e.g. Hames et al, eds.. Nucleic Acid Hybridization: A Practical Approach (IRL Press, Washington, D.C., 1985). In particular, hybridization techniques have been used to select rare cDNA or genomic clones from large libraries by way of mixed oligonucleotide probes, e.g. Wallace et al, Nucleic Acids Research, Vol. 6, pgs. 3543-3557 (1979), or by way of interspecies probes, e.g. Gray et al, Proc. Natl. Acad. Sci., Vol. 80, pgs. 5842-5846 (1983). Nucleic acid hybridization has also been used to determine the degree of homology between sequences, e.g. Kafatos et al, Nucleic Acids Research, Vol. 7, pgs. 1541-1552 (1979), and to detect consensus sequences, e.g. Oliphant et al, Meth. Enzymol., Vol. 155, pgs. 568-582 (1987). Implicit to all of these applications is the notion that the known probe sequences contain information about the unknown target sequences. This notion apparently has never been exploited to obtain detailed sequence information about a target nucleic acid. In view of the limitations of current DNA sequencing methods, it would be advantageous for the scientific and industrial communities to have available an alternative method for sequencing DNA which (1) did not require gel electrophoretic separation of similarly sized DNA fragments, (2) had the capability of providing the sequence of very long
DNA chains in a single operation, and (3) was amenable to automation.
Disclosure of the Invention
The invention is directed to a method for determining the nucleotide sequence of a DNA or an RNA molecule using multiple mixed oligonucleotide probes. Sequence information is obtained by carrying out a series of hybridizations whose results provide for each probe the number of times the complement of the probe's sequence occurs in the RNA or DNA whose sequence is to be determined. The nucleotide sequence of the RNA or DNA is reconstructed from this information and from a knowledge of the probes' sequences. The nucleic acid whose sequence is to be determined is referred to herein as the target sequence.
The mixed oligonucleotide probes of the invention are selected from a set whose members' sequences include every possible complementary sequence to subsequences of a predetermined length within the target sequence. The series of hybridizations are separately carried out such that one or more of the probes selected from the set are combined with known quantities of the target sequence, e.g. on a nitrocellulose filter, or like substrate, under conditions which substantially allow only perfectly matched probe sequences to hybridize with the target sequence. Probe sequences having mismatched bases are substantially removed, e.g. by washing, and the quantity of perfectly matched probe remaining hybridized to the target sequence is determined.
In one embodiment of the invention, the set of probes comprises four subsets. Each of the four subsets contains probes representing every possible sequence, with respect to the size of the probe (which is predetermined), of only one of the four bases. For example, the first subset can contain probes where every possible sequence of G is represented; the second subset can contain probes where every possible sequence of T is represented; and so on for C and A. If the probes
were each 8 bases long, a member probe of the adenosine subset can be represented as follows:
Formula I
The symbol (?o)). means that any of the bases C, G, or T
may occupy the position where the symbol is located. Thus, the above probe has a multiplicity, or degeneracy, of 1x1x3x3x1x3x3x1, or 81. When it is clear from the context which subset is being considered, the above notation will be simplified to AAOOAOOA, where A represents deoxyadenosine and 0 represents the absence of deoxyadenosine.
Preferably, base analogs are employed in the oligonucleotide probes whose base pairing characteristics permit one to reduce the multiplicity of the probe. For example, in the probe of Formula II, because deoxyinosine (I) forms nearly equally strong base pairs with A and C, but forms only a weak or destabilizing base pair with either G or T, deoxyinosine can replace G and T in the probe, Martin et al. Nucleic Acids Research, Vol. 13, pgs. 8927-8938 (1985). Thus, a probe equivalent to that of Formula I, but which has a much lower multiplicity (i.e. only 16) can be represented as follows:
Formula II Generally, base analogs are preferred which form strong base pairs (i.e., comparable in binding energy to the natural base pairs) with two or three of the four natural bases, and a weak or destabilizing base pair with the complement of a fixed base (defined below). Such base analogs are referred to
herein as degeneracy-reducing analogs.
It is not critical that the probes all have the same length, although it is important that they have known lengths and that their sequences be predetermined. Generally, the probes will be fixed at a predetermined number of positions with known bases (not necessarily of the same kind), e.g. as the A in Formula I, and the remaining positions will each be filled by a base randomly selected from a predetermined set, e.g. T, G, and C as in Formula I, or I and C as in Formula II. The positions in a probe which are non- degenerate in their base pairing, i.e. have only a single natural base, are referred to herein as fixed positions. The bases occupying fixed positions are referred to herein as fixed bases. For example, the fixed bases in the probes of Formulas I and II are deoxyadenosine at positions one, two, five, and eight with respect to the 3' end of the probe.
Generally, sets and/or subsets of the invention each contain at least one probe having a sequence of fixed and non- fixed positions equivalent to that of each permutation of a plurality of fixed and non-fixed positions less than or equal to the length of the probe. That is, an important feature of the invention is that the probes collectively contain •subsequences (up to the total length of the probe) which correspond to every possible permutation of fixed and non- fixed positions of each of a plurality of combinations of fixed and non-fixed positions, the plurality including combinations containing from zero to all fixed positions. For example, consider a subset of probes of the invention that consists of 8-mer probes whose fixed positions contain only deoxyadenosine and whose initial (i.e., 3'-most) position is fixed. The probes of Formulas I and II are members of such a subset. Within such a subset, there is a least one probe having a subsequence of fixed and non-fixed positions in positions 2 through 8 which corresponds to each possible permutation of fixed and non-fixed positions for subsequences having no fixed positions (one such permutation: A0000000), one fixed position (seven such permutations, e.g. A000A000),
two fixed positions (twenty-one such permutations, e.g. A00AA000), three fixed positions (thirty-five such permutations, e.g. AOOOOAAA), four fixed positions (thirty- five such permutations, e.g. AOAAAAOO), five fixed positions (twenty-one such permutations, e.g. AAAOOAAA), six fixed positions (seven such permutations, e.g. AAAAOAAA), and seven fixed positions (one such permutation: AAAAAAAA). Thus, the subset has at least 1 + 7 + 21 + 35 + 35 + 21 + 7 + 1 = 128 members.
The presence of one or more predetermined known sequence regions in the target sequence facilitates the reconstruction of the target sequence. Accordingly, in a preferred embodiment, the target sequence contains one or more regions of known sequence, these regions being referred to herein as known sequence regions. More preferably, the target sequence contains a first and a second known sequence region, the first and second known sequence regions being positioned on opposite ends of the region of the target sequence containing the unknown, sequence of nucleotides. This unknown sequence of nucleotides is referred to herein as the unknown sequence region. Most preferably, the first and second known sequence regions are at least the length of the longest probe sequence.
I. Composition and Labeling of the Probes
Mixed oligonucleotide probes for the invention are preferably synthesized using an automated DNA synthesizer, e.g. Applied Biosystems (Foster City, CA) models 381A or 38OB, or like instrument. At non-fixed positions mixtures of the appropriate nucleotide precursors are reacted with the growing oligonucleotide chain so that oligonucleotides having different different bases at that position are synthesized simultaneously, e.g. as disclosed by Wallace et al, Nucleic Acids Research, Vol. 6, pgs.3543-3557 (1979), and Oliphant et al, Meth. Enzymol., Vol. 155, pgs. 568-582 (1987). The probes may be synthesized by way of any of the available chemistries, e.g. phosphite triester, Beaucage et al.
Tetrahedron Letters, Vol. 22, pgs. 1859-1862 (1981); Caruthers et al, U.S. patents 4,415,723, 4,458,066, and 4,500,707; phosphotriester, Itakura, U.S. patent 4,401,796; hydrogen phosphonate, e.g. Froehler et al, Nucleic Acids Research, Vol. 14, pgs. 5399-5407 (1986); or the like. Once synthesized, the oligonucleotides are purified for labeling by well known techniques, usually HPLC or gel electrophoresis, e.g. Applied Biosystems DNA Synthesizer Users Bulletin, Issue No. 13-Revised (April 1, 1987).
Selecting the lengths of the probes is an important aspect of the invention. Several factors influence the choice of length for a given application, including (1) the ease with which hybridization conditions can be manipulated for preferentially hybridizing probes perfectly matched to the target sequence, (2) the ability to distinguish between roughly integral amounts of perfectly matched probe hybidized to the target sequence (e.g. if the probe is relatively long so that the expected frequency of probe sequences perfectly complementary to the target is low, one may be required to distinguish (for example) between amounts of probe in the range of 10, 20, or 30 picomoles—to infer that 1, 2, or 3 copies of the probe are present on the target; if the probe is relatively short so that the expected frequency of probe sequences perfectly complementary to the target is high, one may be required to distinguish (for example) between amounts of probe in the range of 110, 120, or 130 picomoles—to infer that 11, 12, or 13 copies of the probe are present on the target; since the fractional differences between the latter quantities are small, there may be less confidence in the inferred copy number); (3) whether probe multiplicity permits hybridization with reasonable Cot values (longer probes are more degenerate than shorter probes, and require higher Cot values for hybridization, the converse is true of shorter probes); (4) the practicality of carrying out separate hybridizations for each type of probe (longer probes give rise to larger sets of probes, as described above); and (5) the tractability of the sequence reconstruction problem (the greater the number of
copies of each probe type on the target sequence—which is the tendency if shorter probes are employed, the more difficult the reconstruction problem). Probe sizes in the range of 7 to 11 bases are preferred. More preferably, probes sizes are in the range of 8 to 10 bases, and most preferably, probe sizes are in the range of 8 to 9 bases.
Preferably, degeneracy-reducing analogs are employed at the non-fixed positions of the probes to reduce probe multiplicity, or degeneracy. Many synthetic and natural nucleoside and nucleotide analogs are available for this purpose, e.g. Scheit, Nucleotide Analogs (John Wiley & Sons, New York, 1980). For example, degeneracy-reducing analogs include deoxyinosine for use in cytosine or adenosine probes to replace G and T at non-fixed positions, 2-aminopurine for use in cytosine or guanosine probes to replace A and T at non-fixed positions, and N4- methoxydeoxycytidine, N - aminodeoxycytidine, or 5-fluorodeoxyuridine for use in adenosine or guanosine probes to replace T and C. Use of deoxyinosine in oligonucleotide probes is disclosed by Martin et al (cited above); Seela et al. Nucleic Acids Research, Vol. 14, pgs. 1825-1844 (1986); Kawase et al, Nucleic Acids Research, Vol. 14, pgs. 7727-7737 (1986); Ohtsuka et al, J. Biol. Chem., Vol. 260, pgs. 2605-2608 (1985); and Takahashi et al,Proc. Natl. Acad. Sci., Vol. 82. pgs. 1931-1935 (1985). Deoxyinosine phosphoramidite precursors for automated DNA synthesis are available commercially, e.g. Applied Biosystems (Foster City, CA). The synthesis of N4-methoxycytidine and its incorporation into oligonucleotide probes is disclosed by Anand et al. Nucleic Acids Research, Vol. 15, pgs. 8167-8176 (1987). The synthesis of 2-aminopurine and its incorporation into oligonucleotide probes is disclosed by Eritja et al. Nucleic Acids Research, Vol. 14, pgs. 5869-5884 (1986). The synthesis of 5-fluorodeoxyuridine and its incorporation into oligonucleotide probes is disclosed by Habener et al, Proc. Natl. Acad. Sci., Vol. 85, pgs. 1735-1739 (1988). And the preparation of N4-aminodeoxycytidine is disclosed by
Negishi et al. Nucleic Acids Research, Vol. 11, pgs. 5223- 5233 (1983).
Nucleoside analogs are also employed in the invention to reduce the differences in binding energies between the various complementary bases. In particular, 2-aminoadenine can replace thymine in either the probe or target sequences to reduce the binding energy differences between A-T nucleoside pairs and G-C nucleoside pairs, e.g. Kirnos et al (cited above), Choilet et al (cited above), and Cheong et al. Nucleic Acids Research, Vol. 16, pgs. 5115-5122 (1988). Procedures for synthesizing oligonucleotides containing 2-aminoadenine are disclosed by Choilet et al (cited above); Gaffney et al. Tetrahedron, Vol. 40, pgs. 3-13 (1984), and Choilet et al Chemica Scripta, Vol. 26, pgs. 37-40 (1986). Likewise, 2- amino-2'-deoxyadenosine can replace deoxyadenosine to increase the binding energy at positions where A-T pairs occur, e.g. Huynh-Dihn et al, Proc. Natl. Acad. Sci., Vol. 82, pgs. 7510- 7514 (1985).
In some embodiments, it may be preferable to replace a more degenerate probe with several less degenerate probes which collectively are capable of obtaining the same information about the target sequence. For example, consider the 9-mer probe A00000000. This probe can be replaced by the three less degenerate probes A0000000C, A0000000G, and A0000000T. Thus, at the cost of two additional hybridizations, the degeneracy of the most degenerate probe in the set is reduced from 256 to 128 (assuming the use of deoxyinosine at non-fixed positions).
The oligonucleotides of the invention can be labeled in a variety of ways to form probes, including the direct or indirect attachment of radioactive moieties, fluorescent moieties, electron dense moieties, and the like. It is only important that each sequence within a probe be capable of generating a signal of the same magnitude, so that quantitative measurements of probe number can be made. There are several means available for derivatizing oligonucleotides with reactive functionalities which, permit the addition of a label, e.g. Connolly, Nulceic Acids
Research, Vol 15, pgs. 3131-3139 (1987); Gibson et al. Nucleic Acids Research, Vol. 15, pgs. 6455-6467 (1987); Spoat et al. Nucleic Acids Research, Vol. 15, pgs. 4837-4848 (1987); and Mathews et al. Anal. Biochem., Vol. 169, pgs. 1-25 (1988).
In one preferred embodiment, the oligonucleotides of the invention are radioactively labeled with -2P using standard protocols, e.g. Maxim and Gilbert, Meth. Enzymol., Vol. 65, pgs. 499-560 (1980). 32P-labeled probes of the invention are preferably applied to targent DNAs anchored to nitrocellulose, nylon, or the like, at a concentration in the range of about 1-10 ng/ml, and more preferably, in the range of about 1-5 ng/ml. The specific activities of the probe are preferably in the range of about 1-5 X 10° cpm/ml.
II. Hybridization
The hybridizations of the probes to the target sequence are carried out in a manner which allows mismatched probe sequences and nonspecifically bound probe sequences to be separated from the duplexes formed between the perfectly matched probe sequences and the target sequence. Usually the separation is carried out by a washing step. Preferably, the first step in the hybridizations is to anchor the target sequence so that washes and other treatments can take place with minimal loss of the target sequences. The method selected for anchoring the target sequence depends on several factors, including the length of the target, the method used to prepare copies of the target, and the like. Preferably, the target sequence is anchored by attaching it to a substrate or solid phase support, such as nitrocellulose, nylon-66, or the like, or such as derivatized microsphereε, e.g. Kremsky et al. Nucleic Acids Research, Vol. 15, pgs.2891- 2909 (1987).
A known quantity of single or double stranded copies of the target sequence is anchored to the substrate, or solid phase support. As used herein "known quantity" means amounts from which integral numbers of perfectly matched probes can be determined. In some embodiments this means known gram or molar quantities of the target sequence. In
other embodiments, it can mean equal amounts of target sequence on the plurality of solid phase supports, so that signals corresponding to integral numbers of probes can be discerned by comparing signals from the plurality of supports, or by comparing signals to specially provided standards. Preferably, the anchoring means is loaded to capacity with the target sequence so that maximal signals are produced after hybridization. The target sequence can be prepared in double stranded form, denatured, and then applied to the anchoring means, which is preferably a solid phase support, such as nitrocellulose, GeneScreen, or the like. When the target sequence is prepared in double stranded form, it is preferably excised from its cloning vector with one or more endonucleases which leave blunt ended fragments, e.g. Eco RV,A.u I, Bal I, Dra I, Nae I, Sma I, or the like. In this case, both the coding, or sense, strand and the noncoding, or antisense, strand are sequenced simultaneously. Because of sequence complementarity, the reconstruction problem is no more difficult than in the single stranded case.
Suitable vectors for preparing double stranded target sequences are those of the pUC series, e.g. Yanisch-Perron et al, Gene, Vol. 33, pgs. 103-119 (1985). These vectors are readily modified by adding unique restriction sites to their polylinker regions. The new unique restriction sites are selected from restriction endonucleases that leave flush-ended fragments after digestion. For example, chemically synthesized fragments containing such sites can be inserted into the Hind III and Eco RI sites of pUC18 or pUC19. For these vectors such sites include Bal I, Eco RV, Hpa I, -Nae I, Nru I, Stu I, Sna BI, and Xca I. With the modified pUC, the precursor of the target sequence (i.e. the unknown sequence region) can be inserted into a preexisting polylinker site, e.g. Bam HI; the vector can be amplified and isolated; and the target sequence can be excised via the restriction endonucleases that leave flush-ended fragments. The fragments of the polylinker region excised along with the unknown sequence region then become the known sequence regions of the
target sequence.
The preferred method of anchoring DNA to nitrocellulose filters is essentially that described by Kafatos et al (cited above). Up to about 1 ug of target sequence is applied per square millimeter of the filter. Before application the DNA is denatured, preferably in 0.3 to 0.4 N NaOH for about 10 minutes, after which it is chilled with an equal volume of cold water, or optionally cold 2 M ammonium acetate, to a concentration of about 16 ug/ml. Known quantities of the denatured target are spotted onto the filter by carefully controlling the volume of liquid deposited. After each sample is spotted (approximately 1.5 minutes), the filter can optionally be rinsed through with a drop of 1 M ammonium acetate containing about .02-0.2 N NaOH, pH 7.8-9.0. Filters may also be washed with 4xSSC (defined below), e.g. about 200 ml. The filters are air dried, shaken in 2x Denhardt's solution (defined below) for at least 1 hour, drained and air dried again, and baked under vacuum at 80° C for about 2 hours.
Hybridization of the probes to the target sequence usually comprises three steps: a prehybridization treatment, application of the probe, and washing. The purpose of the prehybridization treatment is to reduce nonspecific binding of the probe to the anchoring means and non-target nucleic acids. This is usually accomplished by blocking potential nonspecific binding sites with blocking agents such as proteins, e.g. serum albumin (a major ingredient of Denhardt's solution). For target sequences anchored to nitrocellulose or nylon-66 (e.g. GeneScreen, Nytran, or the like), prehybridization treatment can comprise treatment with 5-10x Denhardt's solution, with 2-6x SSC preferably containing a mild detergent, e.g. 0.5% sodium dodecylsulfate (SDS), for 15 min. to 1 hr. at a temperature in the range of about 25° to 60°. Denhardt's solution, disclosed in Biochem. Biophys. Res. Commun., Vol. 23, pgs. 641-645 (1966), consists at lOx concentration of 0.2% bovine serum albumin, 0.2% polyvinylpyrolidone, and 0.2% Ficoll. SSC, another standard
reagent in the hybridization art, consists at lx of 0.15 M NaCl, 0.015 M sodium citrate, at pH 7.0. Preferred treatment times, temperatures, and formulations may vary with the particular embodiment.
Preferably, the probe is applied to the anchored DNA at a concentration in the range of about 1-10 ng/ml in a solution substantially the same as the prehybridization solution, e.g. 5-10x Denhardt's solution with 2-6x SSC and a mild detergent, e.g. 0.5% SDS. More preferably, the probe concentration is in the range of about 1-5 ng/ml. Preferably, the hybridization is carried out at a temperature 10-20° C below the expected 50% dissociation temperatue, TJ, between the probe and the target. That is, a temperature is selected at which a high proportion, e.g. greater than 80-90%, of all the perfectly matched probes form stable duplexes. For 8-mer probes the preferred hybridization temperature is in the range of about 10-18° C. Hybridization times are preferably in the range of about 3-16 hours. Different hybridization times may be selected for probes of different degrees of degeneracy, because the effective consentrations of particular sequences within a highly degenerate probe, e.g. 0A000000, are considerably less than those of particular sequences in a low degeneracy probe, e.g. AAAOAAAA. Thus, higher Cot values (which usually means longer hybridization times) may be required for more degenerate probes to attain a sufficient degree of binding of perfectly matched sequences. Preferably, a single hybridization time is selected for all probes which is determined by the hybridization kinetics of the most degenerate probe. Probe degeneracy becomes important when relative signals are compared after autoradiography. Probes having higher degeneracy will produce lower signals than probes of lower degeneracy. Therefore, relative signals should only be compared among autoradiographs associated with probes of equivalent degeneracy. Signal comparisons are aided by the simultaneous running of positive and negative controls for each probe, or at least for each degeneracy class.
Removing nonspecifically bound and mismatched probe sequences by washing is an important aspect of the invention. Temperatures and wash times are selected which permit the removal of a maximum amount of nonspecifically bound and mismatched probe sequences, while at the same time permit the retention of a maximum number of probe sequences forming perfectly matched duplexes with the target. The length and base composition of the probe are two important factors in determining the appropriate wash temperature. For probe lengths in the preferred range of 7-11 bases, the difference in duplex stability between perfectly matched and mismatched probe sequences is quite large, the respective T^'s differing by perhaps as much as 10° C, or more. Thus, it is not difficult to preferentially remove mismatches by adjusting wash temperature. On the other hand, composition differences, e.g. G-C content versus A-T content, give rise to a broadened range of probe T^'s, and lower wash temperatures reduce the ability to remove nonspecifically bound probe. Consequently, the wash temperature must be maximized for removing nonspecifically bound probe, yet it cannot be so high as to preferentially remove perfectly matched probes with relatively high A-T content.
Preferably, hybridization conditions and/or nucleotide analogs are selected which minimize the difference in binding energies of the various base pairs, in order to minimize sequence-specific differences in probe binding. Such minimization is preferable because it increases the sensitivity with which perfectly matched probes can be detected. Sensitivity is increased because such minimization makes the transition from probe/target duplexes to single stranded probe and single stranded target much sharper when temperature is increased, i.e. the probe/target Tm is less broad. For example, when hybridization occurs in the presence of tetraalkylammonium salts, the differences in binding energy between G-C pairs and A-T pairs is reduced, e.g. Wood et al, Proc. Natl. Acad. Sci., Vol. 82, pgs. 1585-1588 (1985). Likewise, use of alpha-anomeric nucleoside analogs results in
stronger binding energies, e.g. Moran et al. Nucleic Acids Research, Vol. 16, pgs. 833-847 (1988); and the use of 2- aminoadenine in place of adenine results in stronger binding, e.g. Chollet et al. Nucleic Acid Research, Vol 16, pgs. 305- 317 (1988). Accordingly, a preferred wash procedure for 8-mer probes comprises washing the filters three times for about 15 minutes in 6x SSC containing 0.5% SDS at a temperature in the range of about 10-12° C, followed by one or two rinses with 3.0 M Me4NCl, 50 mM Tris-HCl, pH 8.0, 0.5% SDS, at a temperature in the range of about 10-12° C, followed by a 1.5- 2.5 minute wash in 3.0 M Me4NCl, 50 mM Tris-HCl, pH 8.0, 0.5% SDS, at a temperature in the range of about 24-28° C. For 9- mer probes, the procedure is substantially the same, except that the final wash temperature is preferably in the range of about 26-30°C. After hybridization and washing, quantitative measurements of bound probe are carried out using standard techniques, e.g. for radiolabelled probes, autoradiography or scintillation counting can be used.
III. Sequence Reconstruction
The general nature of the reconstruction problem is illustrated by the example of Figure 1, in which four subsets of 4-mer probes are used to analyze the sequence of the 21- mer, CGAATGGAACTACCGTAACCT. On the left of Figure 1 is a list of 4-mer probes having every possible permutation of fixed and non-fixed positions with respect to deoxyadenosine, deoxycytosine, deoxyguanosine, and thymidine, respectively, for the following combinations of fixed bases and non-fixed bases: 1 fixed and 3 non-fixed, 2 fixed and 2 non-fixed, 3 fixed and 1 non-fixed, and 4 fixed and 0 non-fixed. That is, the list contains at least one probe having a sequence of fixed and non-fixed positions with respect to A, C, G, and T equivalent to every possible permutation of A's and non-fixed positions, C's and non-fixed positions, G's and non-fixed positions, and T's and non-fixed positions, respectively. In the figure, there is one probe for each row of a two dimensional array having a number of columns equal to the
length of the unknown sequence, in this example 21. The data obtained by separately hybridizing the 60 probes to the 21-mer are listed under the column, "Perfect Matches." The data represent the number of each probe type having perfect complementarity with a four base subsequence of the 21- mer. Under the 21-mer sequence itself the probes are positioned along the sequence where perfect complementarity occurs. The objective of a reconstruction algorithm is to determine the positions of enough probes so that the target sequence can be reconstructed.
The reconstruction problem can be approached in many ways. The problem is related to the traveling salesman problem in that it involves finding a permutation of objects which is in some sense optimal. There is an extensive literature on such combinatorial problems which provides guidance in formulating the best approach for a particular embodiment, e.g. Lawler et al, eds., The Traveling Salesman Problem: A Guided Tour of Combinatoria1 Optimization (John Wiley & Sons, New York, 1985); Kirkpatrick, J. Stat. Phys., Vol. 34, pgs. 975-986 (1984); Held and Karp, J. Soc. Indust. Appl. Math., Vol.10, pgs.196-210 (1962); and Lin and Kernighan, Oper. Res., Vol 21, pgs. 498-516 (1973). A preferred approach to the reconstruction problem requires that the target sequence include one or more known sequence regions. In particular, a first known sequence region is located at one end of the target sequence and a second known sequence region is located at the other end of the target sequence. The presence of the two known sequence regions permits the construction of a simplified and efficient reconstruction algorithm. Roughly, the reconstruction problem is a problem of finding an ordering of overlapping probe sequences which corresponds to the target sequence. The known sequence regions define the starting and ending probes sequences in a reconstruction. The intervening unknown sequence region can be reconstructed from the remaining probe sequences by requiring that each successively selected probe properly overlap the previously selected probe sequence.
Figure 2 is a flow chart of such an algorithm. It consists of two parts which are performed alternatively, drawing probes from the same set (referred to herein as the data set) determined by the hybridization data: (1) construction of candidate sequences from properly overlapping fixed-initial- position and fixed-final position probes starting from one of the known sequence regions, and (2) construction of candidate sequences from properly overlapping fixed-final-position and fixed-initial-position probes starting from the other known sequence region. The term "properly overlapping" simply means overlapping in the sense described at the beginning of this section and illustrated in Figure 1. Thus, in this algorithm only probes having either a fixed initial position (3') or a fixed final position (5'), or both, are employed in the reconstruction. These two classes of probes are referred to herein as FIP probes and FFP probes.
For the algorithm, two sets of numbers (or logical variables depending on the implementation) are defined by the nucleotide sequences of the first and second known sequence regions. These sets are referred to as the initial left register and the initial right register 2, respectively. The size of the registers depends on the length of the probes employed. Usually the registers have L-l elements, or entries, where L is the length of the probe. Starting with the initial right register, the algorithm compares the entries of the register with every FFP and FIP probe that forms a perfect match with the target sequence, 4. The comparison is between bases 2 through L of the selected probe and the numbers (or entries) 1 through L-l of the right register. That is, base at position 2 is compared to the entry at position 1 of the right register, base at position 3 is compared to the entry at position 2 of the right register, and so on. Initially, as stated above, the entries of the registers are determined by the bases of the first and second known sequence regions. If the comparison results in proper overlap in each of the L-l positions, then the current contents of the register are loaded into a new right register
and then the entries of the new right register are shifted to the right one position. That is, entry 1 of the new right register is moved to position 2, entry 2 is moved to position 3, and so on. Entry L-l is discarded, and the fixed base at the initial position of the probe (or some representation of it) is loaded into position 1. Next, for the new right register and selected probe to be retained for further comparisons, an FFP probe must be found that properly overlaps the register and the initial fixed base of the selected FIP probe (unless of course the FIP probe is also an FFP probe) 8. When such selections are made (i.e. 4 and 8) the selected probe(s) are removed from the data set. The new right register is saved along with and associated set of properly overlapping FIP probes whose selections led to the current register, and an associated set of properly overlapping FFP probes.
After each new right register is formed, one or more left registers are formed, 16 and 18, by extending preexisting left registers in substantially the same way as the right registers, excepts that FFP probes are selected first and positions 1-L of the FFP probe are compared to entries 1-L of the left register. The FIP and FFP probes are selected from the probes remaining in the data set. That is, any probes previously selected to "extend" the right or left registers cannot be selected. This also holds for right registers formed in successive iterations after the first. As a result of these comparisons, pairs of right and left registers are formed, and associated with each pair are four sets of probes, 20: (i) the set of FIP probes selected to extend the right register, (ii) the set of FFP probes selected to properly overlap the right register and FIP probe, (iii) the set of FFP probes selected to extend the left register, and (iv) the set of FIP probes selected to properly overlap the left register and FFP probe. At each step i (see Figure 2), Mi+1 suc*h pairs a*nd associated sets are formed.
The comparisons between probe and register positions are carried out as follows. The register entries are always the
bases A, C, G, or T (or some representation thereof). The probe positions are always occupied by a base or the absence of a base. Recall from above that probes can be represented by the notation, for example, AOAAOOOA. The 0's represent in this case represent either C, G, T, or a degeneracy-reducing analog thereof. In other words, the 0's represent "not A's". The comparisons entail the determination of the truth value of a base (from the register) and a base or a negative of a base (from the probe being compared). For example, if the register entry is A and the probe entry is "not T", then the logical operation of "A AND not T" is logically true. Thus, proper overlap exists. On the other hand, is the probe entry is "not A", then the logical operation of "A AND not A" is logically false. Thus, the overlap is improper and the probe is rejected.
In successive steps, each of the MJ pairs of registers are compared to probes of their respective data sets, generating in turn, a set of Mj_+ pairs of registers. With each step the data set is reduced in size by two or more probes, and the respective canditate sequences are increased in size by one base each. When a register is compared to each of the remaining probes in its associated data set and no probe is found that properly overlaps, the register and its associated sets are discarded 6-14. The algorithm halts when every probe in the data sets have been used (i.e., sorted into one of the four associated sets). If more than one candidate sequences are generated, or if it is desired to check the consistency of the data, the same process of repeated rounds of comparisons can be carried out starting with the initial left register and set of probes that have fixed final positions and a perfect match with the target sequence 10-16. In this case, entries 1 through L-l of the initial left register are compared with probe positions 1 through L-l, respectively, and successive registers, R- after the jth round of comparisons, are generated by shifting current entries to the left and entering the final fixed base of the properly overlapping probe to position L-l of the new
register. In a similar manner to that described above, additional candidate sequences are generated, and are compared to the ones previously generated. Only ones that occur in both sets are retained 18. Further eliminations are possible by requiring that all of the remaining non-fixed final and non-fixed initial position probes find properly overlapping positions within each of the candidates 20.
Preferably, the algorithm is implemented on a computer with parallel processing capabilities. For example, the algoithm of appendix I can be loaded onto each of the nodes of a hypercube parallel processor, e.g. a 1024 node NCUBE/ten computer (Ncube Corp., Beaverton, Oregon).
The above algorithm does not necessarily give a unique solution in every case. Generally, regions of high frequency repeats (e.g. ACACACAC..., GTCGTCGTC..., or the like) or constant regions (e.g. AAAAAAA..., or the like) substantially longer than the probe give rise to non-unique solutions. For example, it is impossible to uniquely reconstruct (with the above algoritm) target sequences which contain long stretches of a single base type within which a few bases of a different type are clustered. Thus, if 4-mer probes were used to reconstruct a sequence with a stretch containing — AAAAAAAAAAAAAAAAAAAAAGCATAAAAAAAAAAAAAA—the position of GCAT within the sequence of A's cannot be unequivocally determined. In some cases, if alternative solutions are found the correct sequence can be discerned by sequencing the non- uniquely determined portions of the target sequence by standard techniques.
Example I. Sequence•Determination of the 119 Basepair Sca-Xmn Fragment of pUC19 with 8-mer Probes A 119 basepair double stranded DNA is obtained by Xmn I and Sea I restriction endonuclease digestion of the pUC19 plasmid, described by Yanisch-Perro et al. Gene, Vol. 33, pgs. 103-119 (1985), and widely available commercially, e.g. Bethesda Research Laboratories (Gaithersburg, MD). Large scale isolation of pUC19 can be carried out by standard
procedures, e.g. as disclosed by Maniatis et al, Molecular Cloning: A Laboratory Manual, (Cold Spring Harbor Laboratory, New York, 1982) (i.e. alkali lysis followed by equilibrium centrifugation in cesium chloride-ethidium bromide gradient). Alternatively, purified pUC19 is purchased commercially as needed, e.g. from Bethesda Research Laboratories.
1 mg pUC19 DNA is precipitated with 95% ethanol, dried, and resuspended in 1 ml of Sca-Xmn restriction buffer (e.g., 50 mM NaCl, 10 mM Tris-HCl (pH 7.8), 10 mM MgCl2, lOmM 2- mercaptoethanol, 100 ug bovine serum albumin) for about 2.0 hours at 37°C. After stopping the reaction by adding 0.5 M EDTA (pH 7.5), the restriction buffer is mixed with xylene cyanol and loaded onto a 8 percent polyacrylamide gel for electrophoresis. The band containing the 119 basepair fragment is excised, and the DNA eluted as described by Maniatis et al, page 178 (cited above).
The fragments are resuspended at 1 ng/100 ul of 0.2 N NaOH for 10 minutes, chilled, and mixed with an equal volume of lOxSSC (1.5 M sodium chloride and 0.15 M sodium citrate). 100 ul samples of this fragment solution are pipetted into the wells of slot-blotting apparatus, e.g. eleven 72-well Minifold II micro-sample filtration manifolds, available from Schleicher and Scheull, Keene, NH), each apparatus holding a GeneScreen membrane that had been previously wetted for 15- 20 minutes in lxSSC. After 2 hours, the solution is gently sucked through the membranes, washed with 2xSSC, and allowed to dry. After drying, the membranes are baked at 80°C for 2-4 hours. Before application of probe, the membranes are treated with prehybridization mixture (lOx Denhardt's with 0.5% SDS for 1 hour at 60°C, followed by washing with 2xSSC).
Probes for hybridization are synthesized by phosphoramidite chemistry on an Applied Biosystems, Inc. model 380A DNA synthesizer. 4 X 196=784 mixed oligonucleotide probes are employed, a probe for each kind of 8-mer sequence having either a fixed initial position or a fixed final position (see Appendix I). Non-fixed positions of the cytosine
and adenosine subsets of probes are filled by deoxyadenosine and deoxyinosine and deoxycytosine and deoxyinosine, respectively. The probes are 32P labelled following the T4 polynucleotide kinase protocol of Maxum and Gilbert (Meth Enzymol., Vol. 65, pgs. 497-560 (1980)), applied to the manifold wells at 18°C for 16 hours at a concentration of 1 ng/ml in 500 ul of hybridization mixture consisting of 5x Denhardt's, 5xSSPE, and 0.5% SDS. After hybridization the membranes are washed 3 times with 6xSSC containing 0.5% SDS at 12°C, followed by 2 rinses with 3.0 M Me4NCl, 50 mM Tris-HCl (pH 8.0), 0.5% SDS at 12°C, and a final 2.0 minute wash in 3.0 M Me4NCl, 50 mM Tris-HCl (pH 8.0), 0.5% SDS at 26-27°. After washing, the dried membranes are autoradiographed on XAR-5 film (or its equivalent) for 2-4 days. "Slots" on the developed film are analyzed on a LKB UltroScan XL Laser Densitometer, or like instrument.
Numbers of perfectly matched probes are determined by comparing the relative signal strengths of probes having the same degree of degeneracy. Also, because a double stranded target sequence is used, the values for probe number used in the reconstruction algorithm are the average of the signal for each probe type and its complement (with respect to the fixed bases). The sequence is reconstructed from the probe number data by program RC0N8, whose source code is listed in the Appendix. RC0N8 assumes that the eight base sequences on each end of the target sequence are known sequence regions. The program returns the noncoding sequence listed in a 3*-5' orientation from left to right.
Example II. Sequence Determination of the 323 Basepair Pvu II Fragment of pUC19 Using 9-mer Probes A 323 basepair double stranded DNA is one of two fragments obtained by Pvu II digestion of pUC19. The same procedure is followed as described in Example I for preparing the 323 basepair Pvu II fragments, denaturing them, and anchoring them to GeneScreen substrates. Pre-hybridization, hybridization, and wash protocols are the same, except that
the final high temperature wash is carried out at 28-29°C.
Probes are synthesized and labeled as in Example I. 1556 probes are employed. A probe is prepared for each 9-mer sequence having a fixed base at the initial or final position (i.e. 389 each for A, C, G, and T probes). As in Example I, probes of the form 100000000 and 000000001 are replaced by three probes having different types of fixed bases, e.g. OOOOOOOOT is replaced by AOOOOOOOT, COOOOOOOT, and G0000000T.
The sequence of the Pvu fragment is reconstructed with a modified version of the program of Appendix I which specifically accommodates 9-mer probe data. Like the 8-mer version, the program assumes that the nine base sequences on each end of the target sequence are known sequence regions.
Brief Description of the Drawings
Figure 1 illustrates the general problem of sequence reconstruction by showing how a 21-mer sequence can be reconstructed by four subsets of 4-mer probes.
Figure 2 is a flow chart diagrammatically illustrating a preferred reconstruction algorithm.
Appendix I. Source Code Listing of Reconstruction Algorithm RC0N8 program RCON8 c c Program RCON8 reconstructs sequences from 8-mer c probes having fixed bases at their initial c positions and fixed bases at their final c positions. c implicit integer*2 (a-z) dimension rl(xx,120) ,r2(xx,120) ,ll(xx,120) ,12(xx,120) dimension dr2(xx,120) ,dll(xx,120) ,dl2(xx,120) ,drlnum(xx) dimension dr2num(xx) ,dllnum(xx) ,dl2num(xx) ,pset(240,2) dimension pnumδ(4,259,8 ) ,rregl(xx,7) ,rreg2(xx,7) dimension lreg2(xx,7) ,lregl(xx,7) dimension tab(4,-4:4) ,drl(xx,120 ) dimension na(259) ,nc(259) ,ng(259) ,nt(259) character*l seql(120) ,seqr(120 ) ,s,pseq8 (4,259,8 ) c character*10 pdata common r1,r2,11,12,drl,dr2,dll,dl2,rregl,rreg2,lregl,
1 pnumδ,tab,drlnum,dr2num,dllnum,dl2num,npx,np0,
2 Ireg2,pset,pseq8 c c READ pseq8 (list of all possible probe types) from c data file. c GENERATE pnum8 from pseq8. c READ probe data from data file and load into arrays c na, DC, ng, and nt. c GENERATE pset from pseq and na, nc, ng, and nt. c READ register transition table values from data file c and load into array tab. c ENTER bases of known sequence regions into arrays c rreg and lreg. c numreg=l c c NUMREG is the current number of rregisters c NPX is the number of probes in the data having c an initial (3") fixed base. c NPXX is the number of probes in the data having c both an initial (3') and final (51) fixed base, c halt=int( (npxx + (npx-npxx)/2)/2) rl(l,l)=0
11(1,1)=0 drlnum(l)=0
dllnum ( l ) =0 ii=0 1000 ii=ii+l c c ii indexes the round of comparisons, ii is also c equal to the current length of candidate sequences. c w=0 do 1100 f=l,numreg do 1200 kk=l,npx-np0 if(ii.eq.l) then if(kk.gt.l .and. pset(kk,l ) .eq.pset(r2(w,ii) ,1)
1 .and. pset(kk,2) .eq.pset(r2(w,ii ),2) .and.
2 skipa.eq.l) goto 1200 skipa=0 do 1550 j=l,7 1550 if(tab(rregl(f, j ) ,pnumδ (pset(kk,2) ,pset(kk,l) ,
1 j+l)).eq.0) goto 1200 else c do 1300 mm=l,ii-l 1300 if(kk.eq.rKf,mm) .or. kk.eq.ll(f,mm) ) goto 1200 do 1400 mm=l,dllnum(f) 1400 if(kk.eq.dlKf,mm) ) goto 1200 if(kk.gt.l .and. pset(kk,l) .eq.pset(r2 (w,ii) ,1)
1 .and. pset(kk,2 ) .eq.pset(r2(w,ii) ,2 ) .and.
2 skipa.eq.l) goto 1200 skipa=0 do 1500 j=l,7 1500 if(tab(rregl(f, j) ,pnumδ (pset(kk,2) ,pset(kk,l) ,
1 j+l)).eq.0) goto 1200 endif c skipb=0 if(pnumδ (pset(kk,2 ) ,pset(kk,1) ,8 ) .It.0 .or. 1 pset(kk,l) .le.3 ) then do 1600 jj=npx-np0+l,npx if(ii.eq.l) then if(jj.gt.l .and. pset( jj,l) .eq.pset(dr2(w,dr2num(w) ) ,
1 1) .and. pset( jj ,2) Leq.pset(dr2(w,dr2num(w) ) ,2 )
2 .and. skipb.eq.l) goto 1600 skipb=0 do 1950 x=l,8 if(x.eq.l) then if(tab(pset(kk,2) ,pnumδ (pset( jj,2) ,pset( jj,l) , 1 1) ) .eq.0) goto 1600 else if(tab(rregl (f,x-1) ,pnumδ (pset( jj ,2 ) ,
1 pset ( jj ,l ) , x) ) . eq. O ) goto .1600 endif 1950 continue else do 1700 mm=l,drlnum(f) 1700 if(jj.eq.drKf,mm) ) goto 1600 do lδOO mm=l,ii-l lδOO if(jj.eq.lKf,mm) ) goto 1600 if(jj.gt.l .and. pset(jj,1) .eq.pset(dr2(w,dr2num(w) ) ,
1 1) .and. pset(jj,2) .eq.pset(dr2(w,dr2num(w) ) ,2)
2 .and. skipb.eq.l) goto 1600 skipb=0 do 1900 x=l,8 if(x.eq.l) then if(tab(pset(kk,2) ,pnum8(pset(jj,2) ,pset(jj,l), 1 1) ) .eq.O) goto 1600 else if(tab(rregl(f,x-1) ,pnumδ(pset(jj,2) , 1 ^ pset(jj,l),x) ) .eq.O) goto 1600 endif 1900 continue endif ksave=kk jsave=jj w0=w c call left(ii,w,f,jsave,ksave) c if(w.eq.wθ) goto 1600 do 2000 k=w0+l,w do 2100 i=l,6 2100 rreg2(k,i+l)=rregl(f,i) rreg2(k,l)=pset(kk,2) do 2600 q=l,drlnum(f) 2600 dr2(k,q)=drl(f,q) dr2num(k)=drlnum(f) + 1 dr2(k,dr2num(k) )=jj 2000 continue if(ii.eq.l) then do 2200 k=w0+l,w 2200 r2(k,l)=kk else do 2300 k=w0+l,w do 2400 x=l,ii-l 2400 r2(k,x)=rl(f,x)
2300 r2(k,ii)=kk endif skipa=l
skipb=l 1600 continue c else jsave=0 ksave=kk w0=w c call left(ii,w,f,jsave,ksave) c if(w.eq.wθ) goto 1200 do 2700 k=w0+l,w do 2800i=l,6 2800 rreg2(k,i+l)=rregl(f,i) rreg2(k,1)=pset(kk,2) do 2900 q=l,drlnum(f) 2900 dr2(k,q)=drl(f,q) dr2num(k)=dr2num(f) 2700 continue if(ii.eq.l) then do 6000 k=w0+l,w 6000 r2(k,l)=kk
do 7100 m=l,ii rl(k,m)=r2(k,m) 7100 ll(k,m)=12(k,m) do 7200 m=l,7 rregl(k,m)=rreg2(k,m) 7200 lregl(k,m)=lreg2(k,m)
•do 7300 m=l,dr2num(k) 7300 drl(k,m)=dr2(k,m) do 7400 m=l,dl2num(k) 7400 dll(k,m)=dl2(k,m) drlnu (k)=dr2num(k) dllnum(k)=dl2num(k)
7000 continue if (ii.lt.halt) goto 1000 c c PRINT SEQUENCES
C
3000 continue 5000 end c c subroutine left(ii,w,f, jsave,ksave) implicit integer*2 (a-z) dimension rl(xx,120) ,r2(xx,120) ,ll(xx,120) ,12(xx,120) dimension dr2(xx,120) ,dll(xx,120) ,dl2(xx,120) ,drlnum(xx) dimension dr2num(xx) ,dllnum(xx) ,dl2num(xx) ,pset(240,2) dimension pnumδ (4,259,8 ) ,rregl(xx,7) ,rreg2(xx,7) dimension lreg2(xx,7) ,lregl(x ,7) dimension tab(4,-4:4) ,drl(xx,120 ) character*1 pseqδ(4,25 ,δ) common rl,r2,11,12,dr1,dr2,dll,dl2,rregl,rreg2,Iregl,
1 pnumδ,tab,drlnum,dr2num,dllnum,dl2num,npx,np0,
2 Ireg2,pset,pseq8 c skipa=0 do 1000 hh=l,npx if(pnum8(pset(hh,2) ,pset(hh,l) ,8) .lt.O .or. 1 pset(hh,l) .le.3 .or. hh.eq.jsave) goto 1000 if(ii.eq.l) then if(hh.gt.l .and. pset(hh,l) .eq.pset(12(w,ii) ,1)
1 .and. pset(hh,2) .eq.pset(12(w,ii) ,2) .and.
2 skipa.eq.l) goto 1000 skipa=0 do 1350 j=l,7 1350 if(tab(lregl(f,j) ,pnumδ (pset(hh,2) ,pset(hh,l) ,j) ) 1 .eq.O) goto 1000 else c do 1100 mm=l,ii-l 1100 if(hh.eq.rl(f,mm) .or. hh.eq.11 (f,mm) ) goto 1000 do 1200 mm=l,drlnum(f) 1200 if(hh.eq.drl(f,mm) ) goto 1000 if(hh.gt.l .and. pset(hh,l) .eq.pset(12(w,ii) ,1)
1 .and. pset(hh,2) .eq.pset(12(w,ii) ,2) .and.
2 skipa.eq.l) goto 1000 skipa=0 do 1300 j=l,7 1300 if(tab(lregl(f,j) ,pnumδ(pset(hh,2) ,pset(hh,l) , j) )
1 .eq.O) goto 1000 endif
skipb=0 if(pset(hh,l) .ge.137) then do 1400 rr=l,npx-npO if(rr.eq.ksave) goto 1400 if(ii.eq.l) then if(rr.gt.l .and. pset(rr,l) .eq.pset(dl2(w,dl2num(w) ) ,
1 1) .and. pset(rr,2) .eq.pset(dl2(w,dl2num(w) ),2)
2 .and. skipb.eq.l) goto 1400 skipb=0 do 1750 x=l,δ if(x.eq.δ) then if(tab(pnumδ( set(hh,2) ,pset(hh,1) ,x) ,
1 pnumδ(pset(rr,2) ,pset(rr,1) ,x) ) .eq.0)
2 goto 1400 else if(tab(lregl(f,x) ,pnumδ(pset(rr,2) ,pset(rr,1) , 1 x) ) .eq.O) goto 1400 endif 1750 continue else c do 1500 mm=l,dllnum(f) 1500 if(rr.eq.dlKf,mm) ) goto 1400 do 1600 mm=l,ii-l 1600 if(rr.eq.rKf,mm) ) goto 1400 if(rr.gt.l .and. pset(rr,l) .eq.pset(dl2(w,dl2num(w) ) ,
1 1) .and. pset(rr,2) .eq.pset(dl2(w,dl2num(w) ),2)
2 .and. skipb.eq.l) goto 1400 skipb=0 do 1700 x=l,δ if(x.eq.δ) then if(tab(pnumδ(pset(hh,2) ,pset(hh,1) ,x) ,
1 pnumδ(pset(rr,2) ,pset(rr,1) ,x) ) .eq.0)
2 goto 1400 else if(tab(lregl(f,x) ,pnum8(pset(rr,2) ,pset(rr,1) , 1 x) ) .eq.O) goto 1400 endif 1700 continue endif skipa=l skipb=l w=w+l dl2num(w)=dllnum(f)+1 do 1710 k=l,dllnum(f) 1710 dl2(w,k)=dll(f,k) dl2(w,dl2num(w) )=rr
do 1800 i=l,6 1800 lreg2(w,i)=lregl(f,i+l) lreg2(w,7)=pset(hh,2) if(ii.eq.l) then
12(w,l)=hh else - do 1900 k=l,ii-l 1900 12(w,k)=ll(f,k)
12(w,ii)=hh endif 1400 continue else skipa=l w=w+l dl2num( )=dllnum(f) do 2200 j=l,dllnum(f) 2200 dl2(w,j)=dll(f,j) do 2000 i=l,6 2000 lreg2(w,i)=lregl(f,i+l) lreg2(w,7)=pset(hh,2) if(ii.eq.l) then
12(w,l)=hh else do 2100 k=l,ii-l 2100 12(w,k)=ll(f,k)
12(w,ii)=hh endif endif 1000 continue return end
Claims
1. A method for determining the nucleotide sequence of a nucleic acid, the method comprising the steps of: providing a set of probes, each probe within the set having a predetermined length and each probe within the set having a predetermined sequence of fixed and non-fixed positions, the fixed positions comprising one or more predetermined kinds of nucleotides; hybridizing the probes of the set to the nucleic acid; determining the number of copies of each probe in the set that form perfectly matched duplexes with the nucleic acid; and reconstructing the nucleotide sequence of the nucleic acid from the predetermined sequences of the probes that form perfectly matched duplexes with the nucleic acid.
2. The method of claim 1 wherein said set contains at least one probe comprising a sequence of fixed and non- fixed positions equivalent to that of each permutation of a plurality of fixed and non-fixed positions equal to or less than the length of the probe.
3. The method of claim 2 further including the steps of: anchoring a known quantity of said nucleic acid to each of a plurality of solid phase supports; and washing each of the solid phase supports after hybridizing said probes so that substantially all of said probes not forming perfectly matched duplexes with said nucleic acid are removed from the solid phase support, and so that substantially all of said probes forming perfectly matched duplexes with said nucleic acid remain on the solid phase support.
4. The method of claim 3 wherein said step of hybridizing includes separately hybridizing each probe of said set to said nucleic acid on a different solid phase support of said plurality of solid phase supports.
5. The method of claim 4 wherein said predetermined length of said probes are in the range of from seven to eleven nucleotides, inclusive.
6. The method of claim 5 wherein said non-fixed positions of said probes are occupied by at least one degeneracy-reducing analog.
7. A method for determining the nucleotide sequence of a nucleic acid, the method comprising the steps of: providing a first set of probes, each probe within the first set having the same length, the length being from seven to ten nucleotides, and each probe within the first set having a predetermined sequence of fixed and non-fixed bases, the fixed bases being deoxyadenosine and the non-fixed bases comprising deoxycytosine, deoxygauanosine, thymidine, or a degeneracy-reducing analog thereof, such that for each permutation of fixed and non-fixed bases less than or equal to the length of the probe, the first set contains at least one probe having a sequence equivalent to such permutation; providing a second set of probes, each probe within the second set having the same length, the length being from seven to ten nucleotides, and each probe within the second set having a predetermined sequence of fixed and non-fixed bases, the fixed bases being deoxycytosine and the non-fixed bases comprising deoxyadenosine, deoxygauanosine, thymidine, or a degeneracy-reducing analog thereof, such that for each permutation of fixed and non-fixed bases less than or equal to the length of the probe, the second set contains at least one probe having a sequence equivalent to such permutation; providing a third set of probes, each probe within the third set having the same length, the length being from seven to ten nucleotides, and each probe within the third set having a predetermined sequence of fixed and non-fixed bases, the fixed bases being deoxyguanosine and the non-fixed bases comprising deoxyadenosine, deoxycytosine, thymidine, or a degeneracy-reducing analog thereof, such that for each permutation of fixed and non-fixed bases less than or equal to the length of the probe, the third set contains at least one probe having a sequence equivalent to such permutation; providing a fourth set of probes, each probe within the fourth set having the same length, the length being from seven to ten nucleotides, and each probe within the fourth set having a predetermined sequence of fixed and non-fixed bases, the fixed bases being thymidine and the non-fixed bases comprising deoxyadenosine, deoxycytosine, deoxyguanosine, or a degeneracy-reducing analog thereof, such that for each permutation of fixed and non-fixed bases the length of the probe, the fourth set contains at least one probe having a sequence equivalent to such permutation; anchoring a known quantity of the nucleic acid to each of a plurality of solid phase supports; separately hybridizing each probe of the first, second, third, and fourth sets to the nucleic acid anchored on the solid phase supports; washing each of the solid phase supports after hybridizing said probes so that substantially all of said probes not forming perfectly matched duplexes with the nucleic acid are removed from the solid phase support, and so that substantially all of said probes forming perfectly matched duplexes with the nucleic acid remain on the solid phase support; determining the number of copies of each probe in each set that form perfectly matched duplexes with the nucleic acid; and reconstructing the nucleotide sequence of the nucleic acid from the predetermined sequences of the probes that form perfectly matched duplexes with the nucleic acid.
8. The method of claim 7 wherein said nucleic acid contains at least one known sequence region.
9. The method of claim 8 wherein said probe of said first set having said length from eight to nine nucleotides, said probe of said second set having said length from eight to nine nucleotides, said probe of said third set having said length from eight to nine nucleotides, and said probe of said fourth set having said length from eight to nine nucleotides.
10. The method of claim 9 wherein said degeneracy- reducing analog of said first set includes deoxyinosine, 5-fluorodeoxyuridine, and N4- methoxycytosine, said degeneracy-reducing analog of said second set includes deoxyinosine and 2- aminopurine, and said degeneracy-reducing analog of said third set includes 2-aminopurine and N4- methoxycytosine.
11. The method of claim 10 wherein said step of washing includes exposing said solid phase support to tetramethylammonium chloride at a concentration of between about 2 to 4 moles per liter.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/261,702 US5002867A (en) | 1988-04-25 | 1988-10-24 | Nucleic acid sequence determination by multiple mixed oligonucleotide probes |
US261,702 | 1988-10-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1990004652A1 true WO1990004652A1 (en) | 1990-05-03 |
Family
ID=22994489
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1989/004741 WO1990004652A1 (en) | 1988-10-24 | 1989-10-23 | Dna sequencing by multiple mixed oligonucleotide probes |
Country Status (4)
Country | Link |
---|---|
US (1) | US5002867A (en) |
EP (1) | EP0439550A4 (en) |
JP (1) | JPH04501362A (en) |
WO (1) | WO1990004652A1 (en) |
Cited By (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0392546A2 (en) * | 1989-04-14 | 1990-10-17 | Ro Institut Za Molekularnu Genetiku I Geneticko Inzenjerstvo | Process for determination of a complete or a partial contents of very short sequences in the samples of nucleic acids connected to the discrete particles of microscopic size by hybridization with oligonucleotide probes |
EP0478450A1 (en) * | 1990-09-28 | 1992-04-01 | Bertin & Cie | Method of rapid sequencing of linear and ordered biological sequences |
WO1992010092A1 (en) * | 1990-12-06 | 1992-06-25 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
US5143854A (en) * | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
EP0535242A1 (en) * | 1991-03-18 | 1993-04-07 | Institut Molekulyarnoi Biologii Imeni V.A. Engelgardta Akademii Nauk Sssr | Method and device for determining nucleotide sequence of dna |
US5489678A (en) * | 1989-06-07 | 1996-02-06 | Affymax Technologies N.V. | Photolabile nucleoside and peptide protecting groups |
US5525464A (en) * | 1987-04-01 | 1996-06-11 | Hyseq, Inc. | Method of sequencing by hybridization of oligonucleotide probes |
EP0731173A2 (en) * | 1995-03-10 | 1996-09-11 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin | Method for the direct detection of a few oligonucleotides |
WO1997001645A1 (en) * | 1995-06-28 | 1997-01-16 | Amersham Life Science | Primer walking cycle sequencing |
WO1997005276A2 (en) * | 1995-07-25 | 1997-02-13 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Method of sequencing by oligomer hybridisation |
WO1997010365A1 (en) * | 1995-09-15 | 1997-03-20 | Affymax Technologies N.V. | Expression monitoring by hybridization to high density oligonucleotide arrays |
US5667972A (en) * | 1987-04-01 | 1997-09-16 | Hyseg, Inc. | Method of sequencing of genoms by hybridization of oligonucleotide probes |
US5800992A (en) * | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
US5871928A (en) * | 1989-06-07 | 1999-02-16 | Fodor; Stephen P. A. | Methods for nucleic acid analysis |
US5925525A (en) * | 1989-06-07 | 1999-07-20 | Affymetrix, Inc. | Method of identifying nucleotide differences |
US6025136A (en) * | 1994-12-09 | 2000-02-15 | Hyseq, Inc. | Methods and apparatus for DNA sequencing and DNA identification |
US6107031A (en) * | 1993-07-23 | 2000-08-22 | Hyseq, Inc. | Method for screening for unknown organisms |
US6136269A (en) * | 1991-11-22 | 2000-10-24 | Affymetrix, Inc. | Combinatorial kit for polymer synthesis |
US6153379A (en) * | 1993-06-22 | 2000-11-28 | Baylor College Of Medicine | Parallel primer extension approach to nucleic acid sequence analysis |
US6156501A (en) * | 1993-10-26 | 2000-12-05 | Affymetrix, Inc. | Arrays of modified nucleic acid probes and methods of use |
US6297006B1 (en) | 1997-01-16 | 2001-10-02 | Hyseq, Inc. | Methods for sequencing repetitive sequences and for determining the order of sequence subfragments |
US6309824B1 (en) | 1997-01-16 | 2001-10-30 | Hyseq, Inc. | Methods for analyzing a target nucleic acid using immobilized heterogeneous mixtures of oligonucleotide probes |
US6355419B1 (en) | 1998-04-27 | 2002-03-12 | Hyseq, Inc. | Preparation of pools of nucleic acids based on representation in a sample |
US6383742B1 (en) | 1997-01-16 | 2002-05-07 | Radoje T. Drmanac | Three dimensional arrays for detection or quantification of nucleic acid species |
US6596856B2 (en) | 1998-07-31 | 2003-07-22 | Affymetrix, Inc. | Nucleic acid labeling compounds |
EP1382386A2 (en) * | 1992-02-19 | 2004-01-21 | The Public Health Research Institute Of The City Of New York, Inc. | Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids |
US6689563B2 (en) | 1998-10-13 | 2004-02-10 | Brown University Research Foundation | System and methods for sequencing by hybridization |
US6864059B2 (en) | 1996-01-23 | 2005-03-08 | Affymetrix, Inc. | Biotin containing C-glycoside nucleic acid labeling compounds |
WO2005093094A2 (en) * | 2004-03-25 | 2005-10-06 | Genizon Svenska Ab | Methods and means for nucleic acid sequencing |
US6965020B2 (en) | 1996-01-23 | 2005-11-15 | Affymetrix, Inc. | Nucleic acid labeling compounds |
US7001722B1 (en) | 1993-06-22 | 2006-02-21 | Baylor College Of Medicine | Parallel primer extension approach to nucleic acid sequence analysis |
US7056666B2 (en) | 1990-12-06 | 2006-06-06 | Affymetrix, Inc. | Analysis of surface immobilized polymers utilizing microfluorescence detection |
US7071324B2 (en) | 1998-10-13 | 2006-07-04 | Brown University Research Foundation | Systems and methods for sequencing by hybridization |
US7282327B2 (en) | 1996-01-23 | 2007-10-16 | Affymetrix, Inc. | Nucleic acid labeling compounds |
US7291463B2 (en) | 1996-01-23 | 2007-11-06 | Affymetrix, Inc. | Nucleic acid labeling compounds |
US7375198B2 (en) | 1993-10-26 | 2008-05-20 | Affymetrix, Inc. | Modified nucleic acid probes |
US7423143B2 (en) | 1996-01-23 | 2008-09-09 | Affymetrix. Inc. | Nucleic acid labeling compounds |
WO2008134867A1 (en) * | 2007-05-04 | 2008-11-13 | Genizon Biosciences Inc. | Methods, kits, and systems for nucleic acid sequencing by hybridization |
US7468243B2 (en) | 2001-03-12 | 2008-12-23 | Affymetrix, Inc. | 2-aminopyrimidin-4-one nucleic acid labeling compounds |
US7691330B1 (en) | 1991-11-22 | 2010-04-06 | Affymetrix, Inc. | Combinatorial strategies for polymer synthesis |
US7833708B2 (en) | 2001-04-06 | 2010-11-16 | California Institute Of Technology | Nucleic acid amplification using microfluidic devices |
EP2379748A2 (en) * | 2008-12-23 | 2011-10-26 | Illumina, Inc. | Multibase delivery for long reads in sequencing by synthesis protocols |
US8658418B2 (en) | 2002-04-01 | 2014-02-25 | Fluidigm Corporation | Microfluidic particle-analysis systems |
US8859201B2 (en) | 2010-11-16 | 2014-10-14 | Nabsys, Inc. | Methods for sequencing a biomolecule by detecting relative positions of hybridized probes |
US8882980B2 (en) | 2008-09-03 | 2014-11-11 | Nabsys, Inc. | Use of longitudinally displaced nanoscale electrodes for voltage sensing of biomolecules and other analytes in fluidic channels |
US8926813B2 (en) | 2008-09-03 | 2015-01-06 | Nabsys, Inc. | Devices and methods for determining the length of biopolymers and distances between probes bound thereto |
US9051609B2 (en) | 2007-10-01 | 2015-06-09 | Nabsys, Inc. | Biopolymer Sequencing By Hybridization of probes to form ternary complexes and variable range alignment |
US9217177B2 (en) | 2005-02-01 | 2015-12-22 | Applied Biosystems, Llc | Methods for bead-based sequencing |
US9434981B2 (en) | 2010-09-27 | 2016-09-06 | Nabsys 2.0 Llc | Assay methods using nicking endonucleases |
US9579650B2 (en) | 2002-10-02 | 2017-02-28 | California Institute Of Technology | Microfluidic nucleic acid analysis |
US9650668B2 (en) | 2008-09-03 | 2017-05-16 | Nabsys 2.0 Llc | Use of longitudinally displaced nanoscale electrodes for voltage sensing of biomolecules and other analytes in fluidic channels |
US9714443B2 (en) | 2002-09-25 | 2017-07-25 | California Institute Of Technology | Microfabricated structure having parallel and orthogonal flow channels controlled by row and column multiplexors |
US9765391B2 (en) | 2005-07-20 | 2017-09-19 | Illumina Cambridge Limited | Methods for sequencing a polynucleotide template |
US9914966B1 (en) | 2012-12-20 | 2018-03-13 | Nabsys 2.0 Llc | Apparatus and methods for analysis of biomolecules using high frequency alternating current excitation |
US10294516B2 (en) | 2013-01-18 | 2019-05-21 | Nabsys 2.0 Llc | Enhanced probe binding |
US11274341B2 (en) | 2011-02-11 | 2022-03-15 | NABsys, 2.0 LLC | Assay methods using DNA binding proteins |
Families Citing this family (215)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8810400D0 (en) * | 1988-05-03 | 1988-06-08 | Southern E | Analysing polynucleotide sequences |
US6054270A (en) * | 1988-05-03 | 2000-04-25 | Oxford Gene Technology Limited | Analying polynucleotide sequences |
US20050032048A1 (en) * | 1988-05-03 | 2005-02-10 | Oxford Gene Technology Limited | Analyzing polynucleotide sequences |
US7811751B2 (en) * | 1988-05-03 | 2010-10-12 | Oxford Gene Technology Limited | Analysing polynucleotide sequences |
US5700637A (en) * | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
US5595870A (en) * | 1989-02-17 | 1997-01-21 | The Trustees Of Columbia University In The City Of New York | Identifying nucleic acids by restriction digestion and hybridization with random or pseudorandom oligonucleotides |
US6309822B1 (en) | 1989-06-07 | 2001-10-30 | Affymetrix, Inc. | Method for comparing copy number of nucleic acid sequences |
US6406844B1 (en) | 1989-06-07 | 2002-06-18 | Affymetrix, Inc. | Very large scale immobilized polymer synthesis |
US6955915B2 (en) * | 1989-06-07 | 2005-10-18 | Affymetrix, Inc. | Apparatus comprising polymers |
US6346413B1 (en) | 1989-06-07 | 2002-02-12 | Affymetrix, Inc. | Polymer arrays |
US6919211B1 (en) * | 1989-06-07 | 2005-07-19 | Affymetrix, Inc. | Polypeptide arrays |
US5424186A (en) | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
US6416952B1 (en) | 1989-06-07 | 2002-07-09 | Affymetrix, Inc. | Photolithographic and other means for manufacturing arrays |
US6551784B2 (en) | 1989-06-07 | 2003-04-22 | Affymetrix Inc | Method of comparing nucleic acid sequences |
US6506558B1 (en) | 1990-03-07 | 2003-01-14 | Affymetrix Inc. | Very large scale immobilized polymer synthesis |
EP0834576B1 (en) * | 1990-12-06 | 2002-01-16 | Affymetrix, Inc. (a Delaware Corporation) | Detection of nucleic acid sequences |
US6849462B1 (en) | 1991-11-22 | 2005-02-01 | Affymetrix, Inc. | Combinatorial strategies for polymer synthesis |
US6468740B1 (en) | 1992-11-05 | 2002-10-22 | Affymetrix, Inc. | Cyclic and substituted immobilized molecular synthesis |
US5403708A (en) * | 1992-07-06 | 1995-04-04 | Brennan; Thomas M. | Methods and compositions for determining the sequence of nucleic acids |
US5583211A (en) * | 1992-10-29 | 1996-12-10 | Beckman Instruments, Inc. | Surface activated organic polymers useful for location - specific attachment of nucleic acids, peptides, proteins and oligosaccharides |
US5795714A (en) * | 1992-11-06 | 1998-08-18 | Trustees Of Boston University | Method for replicating an array of nucleic acid probes |
US5503980A (en) * | 1992-11-06 | 1996-04-02 | Trustees Of Boston University | Positional sequencing by hybridization |
US6436635B1 (en) * | 1992-11-06 | 2002-08-20 | Boston University | Solid phase sequencing of double-stranded nucleic acids |
US5556749A (en) * | 1992-11-12 | 1996-09-17 | Hitachi Chemical Research Center, Inc. | Oligoprobe designstation: a computerized method for designing optimal DNA probes |
US5605798A (en) | 1993-01-07 | 1997-02-25 | Sequenom, Inc. | DNA diagnostic based on mass spectrometry |
US5962221A (en) * | 1993-01-19 | 1999-10-05 | Univ Tennessee Res Corp | Oligonucleotide constructs and methods for the generation of sequence signatures from nucleic acids |
US5858659A (en) * | 1995-11-29 | 1999-01-12 | Affymetrix, Inc. | Polymorphism detection |
US6027880A (en) * | 1995-08-02 | 2000-02-22 | Affymetrix, Inc. | Arrays of nucleic acid probes and methods of using the same for detecting cystic fibrosis |
US5861242A (en) * | 1993-06-25 | 1999-01-19 | Affymetrix, Inc. | Array of nucleic acid probes on biological chips for diagnosis of HIV and methods of using the same |
US7115364B1 (en) | 1993-10-26 | 2006-10-03 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
US20030134291A1 (en) * | 1993-06-25 | 2003-07-17 | Affymetrix, Inc. | Polymorphism detection |
EP0705271B1 (en) | 1993-06-25 | 2002-11-13 | Affymetrix, Inc. (a Delaware Corporation) | Hybridization and sequencing of nucleic acids |
US5837832A (en) * | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
US6007987A (en) * | 1993-08-23 | 1999-12-28 | The Trustees Of Boston University | Positional sequencing by hybridization |
US6401267B1 (en) * | 1993-09-27 | 2002-06-11 | Radoje Drmanac | Methods and compositions for efficient nucleic acid sequencing |
US6309823B1 (en) | 1993-10-26 | 2001-10-30 | Affymetrix, Inc. | Arrays of nucleic acid probes for analyzing biotransformation genes and methods of using the same |
DE69433180T2 (en) * | 1993-10-26 | 2004-06-24 | Affymetrix, Inc., Santa Clara | FIELDS OF NUCLEIC ACID PROBE ON ORGANIC CHIPS |
US20060229824A1 (en) * | 1993-10-26 | 2006-10-12 | Affymetrix, Inc. | Arrays of nucleic acid probes for analyzing biotransformation genes |
US5552278A (en) * | 1994-04-04 | 1996-09-03 | Spectragen, Inc. | DNA sequencing by stepwise ligation and cleavage |
WO1995027072A1 (en) * | 1994-04-05 | 1995-10-12 | Pharmagenics, Inc. | Determination and identification of active compounds in a compound library |
US7323298B1 (en) | 1994-06-17 | 2008-01-29 | The Board Of Trustees Of The Leland Stanford Junior University | Microarray for determining the relative abundances of polynuceotide sequences |
US5710000A (en) * | 1994-09-16 | 1998-01-20 | Affymetrix, Inc. | Capturing sequences adjacent to Type-IIs restriction sites for genomic library mapping |
USRE43097E1 (en) | 1994-10-13 | 2012-01-10 | Illumina, Inc. | Massively parallel signature sequencing by ligation of encoded adaptors |
US5604097A (en) | 1994-10-13 | 1997-02-18 | Spectragen, Inc. | Methods for sorting polynucleotides using oligonucleotide tags |
US6600996B2 (en) | 1994-10-21 | 2003-07-29 | Affymetrix, Inc. | Computer-aided techniques for analyzing biological sequences |
US5795716A (en) * | 1994-10-21 | 1998-08-18 | Chee; Mark S. | Computer-aided visualization and analysis system for sequence evaluation |
US8236493B2 (en) * | 1994-10-21 | 2012-08-07 | Affymetrix, Inc. | Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA |
US6974666B1 (en) * | 1994-10-21 | 2005-12-13 | Appymetric, Inc. | Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA |
US20060063193A1 (en) * | 1995-04-11 | 2006-03-23 | Dong-Jing Fu | Solid phase sequencing of double-stranded nucleic acids |
US7803529B1 (en) * | 1995-04-11 | 2010-09-28 | Sequenom, Inc. | Solid phase sequencing of biopolymers |
US5750341A (en) * | 1995-04-17 | 1998-05-12 | Lynx Therapeutics, Inc. | DNA sequencing by parallel oligonucleotide extensions |
US5968740A (en) * | 1995-07-24 | 1999-10-19 | Affymetrix, Inc. | Method of Identifying a Base in a Nucleic Acid |
US5733729A (en) * | 1995-09-14 | 1998-03-31 | Affymetrix, Inc. | Computer-aided probability base calling for arrays of nucleic acid probes on chips |
US20040175718A1 (en) * | 1995-10-16 | 2004-09-09 | Affymetrix, Inc. | Computer-aided visualization and analysis system for sequence evaluation |
US5683881A (en) * | 1995-10-20 | 1997-11-04 | Biota Corp. | Method of identifying sequence in a nucleic acid target using interactive sequencing by hybridization |
US6300063B1 (en) | 1995-11-29 | 2001-10-09 | Affymetrix, Inc. | Polymorphism detection |
US6953663B1 (en) * | 1995-11-29 | 2005-10-11 | Affymetrix, Inc. | Polymorphism detection |
US20040210045A1 (en) * | 1996-01-23 | 2004-10-21 | Mcgall Glenn | Nucleic acid labeling compounds |
EP0880598A4 (en) | 1996-01-23 | 2005-02-23 | Affymetrix Inc | Nucleic acid analysis techniques |
US6361937B1 (en) * | 1996-03-19 | 2002-03-26 | Affymetrix, Incorporated | Computer-aided nucleic acid sequencing |
AU2320597A (en) | 1996-03-19 | 1997-10-10 | Molecular Tool, Inc. | Method for determining the nucleotide sequence of a polynucleotide |
US6458530B1 (en) * | 1996-04-04 | 2002-10-01 | Affymetrix Inc. | Selecting tag nucleic acids |
US7041510B2 (en) | 1996-04-25 | 2006-05-09 | Bioarray Solutions Ltd. | System and method for programmable illumination pattern generation |
ES2288760T3 (en) * | 1996-04-25 | 2008-01-16 | Bioarray Solutions Ltd. | ELECTROCINETIC ASSEMBLY CONTROLLED BY LIGHT OF PARTICLES NEXT TO SURFACES. |
US6958245B2 (en) | 1996-04-25 | 2005-10-25 | Bioarray Solutions Ltd. | Array cytometry |
US7144119B2 (en) * | 1996-04-25 | 2006-12-05 | Bioarray Solutions Ltd. | System and method for programmable illumination pattern generation |
US6387707B1 (en) * | 1996-04-25 | 2002-05-14 | Bioarray Solutions | Array Cytometry |
JP2000512498A (en) * | 1996-06-14 | 2000-09-26 | サルノフ コーポレーション | Polynucleotide sequencing method |
US6391550B1 (en) * | 1996-09-19 | 2002-05-21 | Affymetrix, Inc. | Identification of molecular sequence signatures and methods involving the same |
EP0943012A4 (en) * | 1996-09-19 | 2004-06-30 | Affymetrix Inc | Identification of molecular sequence signatures and methods involving the same |
CA2301230A1 (en) | 1996-09-20 | 1998-03-26 | Digital Drives, Inc. | Spatially addressable combinatorial chemical arrays in cd-rom format |
EP1164203B1 (en) | 1996-11-06 | 2007-10-10 | Sequenom, Inc. | DNA Diagnostics based on mass spectrometry |
US6327410B1 (en) | 1997-03-14 | 2001-12-04 | The Trustees Of Tufts College | Target analyte sensors utilizing Microspheres |
US20030027126A1 (en) | 1997-03-14 | 2003-02-06 | Walt David R. | Methods for detecting target analytes and enzymatic reactions |
US7622294B2 (en) * | 1997-03-14 | 2009-11-24 | Trustees Of Tufts College | Methods for detecting target analytes and enzymatic reactions |
US6023540A (en) | 1997-03-14 | 2000-02-08 | Trustees Of Tufts College | Fiber optic sensor with encoded microspheres |
US7008765B1 (en) * | 1997-04-10 | 2006-03-07 | The Johns Hopkins University | PCA3, PCA3 genes, and methods of use |
US6406845B1 (en) * | 1997-05-05 | 2002-06-18 | Trustees Of Tuft College | Fiber optic biosensor for selectively detecting oligonucleotide species in a mixed fluid sample |
EP0985142A4 (en) | 1997-05-23 | 2006-09-13 | Lynx Therapeutics Inc | System and apparaus for sequential processing of analytes |
EP1003904B1 (en) * | 1997-05-23 | 2007-07-11 | BioArray Solutions Ltd. | Color-encoding and in-situ interrogation of matrix-coupled chemical compounds |
WO1999009217A1 (en) * | 1997-08-15 | 1999-02-25 | Hyseq, Inc. | Methods and compositions for detection or quantification of nucleic acid species |
US7115884B1 (en) | 1997-10-06 | 2006-10-03 | Trustees Of Tufts College | Self-encoding fiber optic sensor |
US7348181B2 (en) | 1997-10-06 | 2008-03-25 | Trustees Of Tufts College | Self-encoding sensor with microspheres |
US6322968B1 (en) | 1997-11-21 | 2001-11-27 | Orchid Biosciences, Inc. | De novo or “universal” sequencing array |
US6210910B1 (en) | 1998-03-02 | 2001-04-03 | Trustees Of Tufts College | Optical fiber biosensor array comprising cell populations confined to microcavities |
US6872521B1 (en) | 1998-06-16 | 2005-03-29 | Beckman Coulter, Inc. | Polymerase signaling assay |
EP1090293B2 (en) | 1998-06-24 | 2019-01-23 | Illumina, Inc. | Decoding of array sensors with microspheres |
US6545264B1 (en) | 1998-10-30 | 2003-04-08 | Affymetrix, Inc. | Systems and methods for high performance scanning |
US6451525B1 (en) * | 1998-12-03 | 2002-09-17 | Pe Corporation (Ny) | Parallel sequencing method |
US6429027B1 (en) | 1998-12-28 | 2002-08-06 | Illumina, Inc. | Composite arrays utilizing microspheres |
US7510841B2 (en) * | 1998-12-28 | 2009-03-31 | Illumina, Inc. | Methods of making and using composite arrays for the detection of a plurality of target analytes |
DE60042775D1 (en) * | 1999-01-06 | 2009-10-01 | Callida Genomics Inc | IMPROVED SEQUENCING BY HYBRIDIZATION THROUGH THE USE OF PROBABLE MIXTURES |
US6846460B1 (en) | 1999-01-29 | 2005-01-25 | Illumina, Inc. | Apparatus and method for separation of liquid phases of different density and for fluorous phase organic syntheses |
WO2000047600A1 (en) * | 1999-02-10 | 2000-08-17 | University Of Maryland | Photo-induced nucleic acid hybridization |
US6764820B2 (en) * | 1999-03-26 | 2004-07-20 | Ludwig Institute For Cancer Research | Screening for lymphatic disorders involving the FLT4 receptor tyrosine kinase (VEGFR-3) |
WO2000058511A1 (en) | 1999-03-26 | 2000-10-05 | Ludwig Institute For Cancer Research | Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3) |
US20060275782A1 (en) * | 1999-04-20 | 2006-12-07 | Illumina, Inc. | Detection of nucleic acid reactions on bead arrays |
US20030215821A1 (en) * | 1999-04-20 | 2003-11-20 | Kevin Gunderson | Detection of nucleic acid reactions on bead arrays |
US6355431B1 (en) | 1999-04-20 | 2002-03-12 | Illumina, Inc. | Detection of nucleic acid amplification reactions using bead arrays |
EP1190100B1 (en) | 1999-05-20 | 2012-07-25 | Illumina, Inc. | Combinatorial decoding of random nucleic acid arrays |
US6544732B1 (en) * | 1999-05-20 | 2003-04-08 | Illumina, Inc. | Encoding and decoding of array sensors utilizing nanocrystals |
US8481268B2 (en) | 1999-05-21 | 2013-07-09 | Illumina, Inc. | Use of microfluidic systems in the detection of target analytes using microsphere arrays |
US8080380B2 (en) * | 1999-05-21 | 2011-12-20 | Illumina, Inc. | Use of microfluidic systems in the detection of target analytes using microsphere arrays |
US6334099B1 (en) * | 1999-05-25 | 2001-12-25 | Digital Gene Technologies, Inc. | Methods for normalization of experimental data |
US6692915B1 (en) | 1999-07-22 | 2004-02-17 | Girish N. Nallur | Sequencing a polynucleotide on a generic chip |
DK1218545T3 (en) | 1999-08-18 | 2012-02-20 | Illumina Inc | Methods of Preparation of Oligonucleotide Solutions |
AU2246601A (en) | 1999-08-30 | 2001-04-10 | Illumina, Inc. | Methods for improving signal detection from an array |
PT1222266E (en) * | 1999-09-29 | 2006-07-31 | Diagnocure Inc | PCA3 MESSENGER RNA IN BENEFICIAL AND MALIGNAL PROSTATE TISSUES |
US7167615B1 (en) | 1999-11-05 | 2007-01-23 | Board Of Regents, The University Of Texas System | Resonant waveguide-grating filters and sensors and methods for making and using same |
US20030134293A1 (en) * | 1999-11-16 | 2003-07-17 | Zhiping Liu | Method for rapid and accurate identification of microorganisms |
US20050214825A1 (en) * | 2000-02-07 | 2005-09-29 | John Stuelpnagel | Multiplex sample analysis on universal arrays |
US7955794B2 (en) | 2000-09-21 | 2011-06-07 | Illumina, Inc. | Multiplex nucleic acid reactions |
US7582420B2 (en) | 2001-07-12 | 2009-09-01 | Illumina, Inc. | Multiplex nucleic acid reactions |
US7361488B2 (en) * | 2000-02-07 | 2008-04-22 | Illumina, Inc. | Nucleic acid detection methods using universal priming |
EP1255865B1 (en) | 2000-02-07 | 2007-04-18 | Illumina, Inc. | Nucleic acid detection method using universal priming |
US8076063B2 (en) * | 2000-02-07 | 2011-12-13 | Illumina, Inc. | Multiplexed methylation detection methods |
US7611869B2 (en) * | 2000-02-07 | 2009-11-03 | Illumina, Inc. | Multiplexed methylation detection methods |
US6913884B2 (en) * | 2001-08-16 | 2005-07-05 | Illumina, Inc. | Compositions and methods for repetitive use of genomic DNA |
EP1990428B1 (en) | 2000-02-07 | 2010-12-22 | Illumina, Inc. | Nucleic acid detection methods using universal priming |
US6770441B2 (en) * | 2000-02-10 | 2004-08-03 | Illumina, Inc. | Array compositions and methods of making same |
AU2001239760B2 (en) * | 2000-02-10 | 2005-11-24 | Illumina, Inc. | Array of individual arrays as substrate for bead-based simultaneous processing of samples and manufacturing method therefor |
EP1257668B1 (en) | 2000-02-16 | 2008-10-29 | Illumina, Inc. | Parallel genotyping of multiple patient samples |
ATE423221T1 (en) * | 2000-06-13 | 2009-03-15 | Univ Boston | USE OF MASS-MATCHED NUCLEOTIDES IN THE ANALYSIS OF OLIGONUCLEOTIDE MIXTURES AND IN HIGH-MULTIPLEX NUCLEIC ACID SEQUENCING |
DK1290444T3 (en) | 2000-06-14 | 2010-01-18 | Vistagen Inc | Toxicity typing using liver stem cells |
US9709559B2 (en) | 2000-06-21 | 2017-07-18 | Bioarray Solutions, Ltd. | Multianalyte molecular analysis using application-specific random particle arrays |
ES2259666T3 (en) | 2000-06-21 | 2006-10-16 | Bioarray Solutions Ltd | MOLECULAR ANALYSIS OF MULTIPLE ANALYTICS USING SERIES OF RANDOM PARTICLES WITH APPLICATION SPECIFICITY. |
US7238795B2 (en) * | 2000-08-03 | 2007-07-03 | Roche Molecular Systems, Inc. | Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses |
JP4965793B2 (en) | 2000-09-01 | 2012-07-04 | ジェン−プローブ・インコーポレーテッド | Amplification of HIV-1 sequences for detection of sequences associated with drug resistance mutations |
AU2001288751A1 (en) * | 2000-09-05 | 2002-03-22 | Illumina, Inc. | Cellular arrays comprising encoded cells |
US7057704B2 (en) * | 2000-09-17 | 2006-06-06 | Bioarray Solutions Ltd. | System and method for programmable illumination pattern generation |
US20030045005A1 (en) * | 2000-10-17 | 2003-03-06 | Michael Seul | Light-controlled electrokinetic assembly of particles near surfaces |
US20040018491A1 (en) * | 2000-10-26 | 2004-01-29 | Kevin Gunderson | Detection of nucleic acid reactions on bead arrays |
EP1410044A2 (en) * | 2000-11-08 | 2004-04-21 | Burstein Technologies, Inc. | Interactive system for analyzing biological samples and processing related information and the use thereof |
US6760298B2 (en) * | 2000-12-08 | 2004-07-06 | Nagaoka & Co., Ltd. | Multiple data layer optical discs for detecting analytes |
WO2002046761A2 (en) * | 2000-12-08 | 2002-06-13 | Burstein Technologies, Inc. | Methods for detecting analytes using optical discs and optical disc readers |
JP4588976B2 (en) * | 2001-01-25 | 2010-12-01 | ルミネックス モレキュラー ダイアグノスティックス, インク. | Polynucleotides, products, and uses thereof as tags and tag complements |
US7226737B2 (en) * | 2001-01-25 | 2007-06-05 | Luminex Molecular Diagnostics, Inc. | Polynucleotides for use as tags and tag complements, manufacture and use thereof |
EP1385999B1 (en) * | 2001-04-30 | 2012-12-12 | Ventana Medical Systems, Inc. | Reagents and methods for automated in situ or microarray hybridization |
WO2004010099A2 (en) * | 2001-05-16 | 2004-01-29 | Burstein Technologies, Inc. | Variable sampling for rendering pixelization of analysis results in optical bio-disc assembly |
US6653082B2 (en) | 2001-05-17 | 2003-11-25 | Baylor College Of Medicine | Substrate-bound cleavage assay for nucleic acid analysis |
US7262063B2 (en) | 2001-06-21 | 2007-08-28 | Bio Array Solutions, Ltd. | Directed assembly of functional heterostructures |
EP2722395B1 (en) | 2001-10-15 | 2018-12-19 | Bioarray Solutions Ltd | Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection |
US7499806B2 (en) | 2002-02-14 | 2009-03-03 | Illumina, Inc. | Image processing in microsphere arrays |
US9388459B2 (en) * | 2002-06-17 | 2016-07-12 | Affymetrix, Inc. | Methods for genotyping |
US7108976B2 (en) * | 2002-06-17 | 2006-09-19 | Affymetrix, Inc. | Complexity management of genomic DNA by locus specific amplification |
US7872804B2 (en) * | 2002-08-20 | 2011-01-18 | Illumina, Inc. | Encoded particle having a grating with variations in the refractive index |
US7441703B2 (en) * | 2002-08-20 | 2008-10-28 | Illumina, Inc. | Optical reader for diffraction grating-based encoded optical identification elements |
US20050227252A1 (en) * | 2002-08-20 | 2005-10-13 | Moon John A | Diffraction grating-based encoded articles for multiplexed experiments |
US7923260B2 (en) * | 2002-08-20 | 2011-04-12 | Illumina, Inc. | Method of reading encoded particles |
US7508608B2 (en) * | 2004-11-17 | 2009-03-24 | Illumina, Inc. | Lithographically fabricated holographic optical identification element |
US7164533B2 (en) * | 2003-01-22 | 2007-01-16 | Cyvera Corporation | Hybrid random bead/chip based microarray |
US7901630B2 (en) * | 2002-08-20 | 2011-03-08 | Illumina, Inc. | Diffraction grating-based encoded microparticle assay stick |
US7900836B2 (en) * | 2002-08-20 | 2011-03-08 | Illumina, Inc. | Optical reader system for substrates having an optically readable code |
US20100255603A9 (en) | 2002-09-12 | 2010-10-07 | Putnam Martin A | Method and apparatus for aligning microbeads in order to interrogate the same |
WO2004024328A1 (en) * | 2002-09-12 | 2004-03-25 | Cyvera Corporation | Method and apparatus for aligning elongated microbeads in order to interrogate the same |
US7092160B2 (en) * | 2002-09-12 | 2006-08-15 | Illumina, Inc. | Method of manufacturing of diffraction grating-based optical identification element |
US20040259105A1 (en) * | 2002-10-03 | 2004-12-23 | Jian-Bing Fan | Multiplex nucleic acid analysis using archived or fixed samples |
US7459273B2 (en) * | 2002-10-04 | 2008-12-02 | Affymetrix, Inc. | Methods for genotyping selected polymorphism |
WO2004047007A1 (en) | 2002-11-15 | 2004-06-03 | Bioarray Solutions, Ltd. | Analysis, secure access to, and transmission of array images |
US20040126765A1 (en) * | 2002-12-27 | 2004-07-01 | Adams Craig W. | Method and compositions for sequencing nucleic acid molecules |
US7887752B2 (en) * | 2003-01-21 | 2011-02-15 | Illumina, Inc. | Chemical reaction monitor |
ES2427853T3 (en) | 2003-02-07 | 2013-11-04 | Diagnocure Inc. | Procedure to detect prostate cancer in a sample |
US6943768B2 (en) | 2003-02-21 | 2005-09-13 | Xtellus Inc. | Thermal control system for liquid crystal cell |
CA2463719A1 (en) * | 2003-04-05 | 2004-10-05 | F. Hoffmann-La Roche Ag | Nucleotide analogs with six membered rings |
US8114978B2 (en) | 2003-08-05 | 2012-02-14 | Affymetrix, Inc. | Methods for genotyping selected polymorphism |
WO2005025409A2 (en) * | 2003-09-12 | 2005-03-24 | University Of Cincinnati | Methods for risk assessment, survival prediction and treatment of heart failure and other conditions based on adrenergic receptor polymorphisms |
WO2005029705A2 (en) * | 2003-09-18 | 2005-03-31 | Bioarray Solutions, Ltd. | Number coding for identification of subtypes of coded types of solid phase carriers |
ES2375962T3 (en) | 2003-09-22 | 2012-03-07 | Bioarray Solutions Ltd | IMMOBILIZED SURFACE POLYELECTROLYTE WITH MULTIPLE FUNCTIONAL GROUPS ABLE TO JOIN COVALENTLY TO BIOMOLECULES. |
US20050089916A1 (en) * | 2003-10-28 | 2005-04-28 | Xiongwu Xia | Allele assignment and probe selection in multiplexed assays of polymorphic targets |
EP1692298A4 (en) * | 2003-10-28 | 2008-08-13 | Bioarray Solutions Ltd | Optimization of gene expression analysis using immobilized capture probes |
ES2533876T3 (en) | 2003-10-29 | 2015-04-15 | Bioarray Solutions Ltd | Multiplexed nucleic acid analysis by double stranded DNA fragmentation |
US7972783B2 (en) * | 2003-11-24 | 2011-07-05 | Branhaven LLC | Method and markers for determining the genotype of horned/polled cattle |
US20050147976A1 (en) * | 2003-12-29 | 2005-07-07 | Xing Su | Methods for determining nucleotide sequence information |
US7433123B2 (en) * | 2004-02-19 | 2008-10-07 | Illumina, Inc. | Optical identification element having non-waveguide photosensitive substrate with diffraction grating therein |
US7622281B2 (en) * | 2004-05-20 | 2009-11-24 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for clonal amplification of nucleic acid |
WO2006020363A2 (en) * | 2004-07-21 | 2006-02-23 | Illumina, Inc. | Method and apparatus for drug product tracking using encoded optical identification elements |
US7848889B2 (en) | 2004-08-02 | 2010-12-07 | Bioarray Solutions, Ltd. | Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification |
ES2345993T3 (en) | 2004-09-14 | 2010-10-07 | The Regents Of The University Of Colorado, A Body Corporate | METHOD FOR TREATMENT WITH BUCINDOLOL BASED ON GENETIC ADDRESSING. |
GB0422551D0 (en) * | 2004-10-11 | 2004-11-10 | Univ Liverpool | Labelling and sequencing of nucleic acids |
US7604173B2 (en) * | 2004-11-16 | 2009-10-20 | Illumina, Inc. | Holographically encoded elements for microarray and other tagging labeling applications, and method and apparatus for making and reading the same |
WO2006055736A1 (en) | 2004-11-16 | 2006-05-26 | Illumina, Inc. | And methods and apparatus for reading coded microbeads |
WO2006055735A2 (en) | 2004-11-16 | 2006-05-26 | Illumina, Inc | Scanner having spatial light modulator |
US20060121491A1 (en) * | 2004-12-02 | 2006-06-08 | Wolber Paul K | Partially degenerate oligonucleotide standards and methods for generating the same |
CA2491067A1 (en) | 2004-12-24 | 2006-06-24 | Stichting Katholieke Universiteit | Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer |
US20060246576A1 (en) * | 2005-04-06 | 2006-11-02 | Affymetrix, Inc. | Fluidic system and method for processing biological microarrays in personal instrumentation |
US7452671B2 (en) * | 2005-04-29 | 2008-11-18 | Affymetrix, Inc. | Methods for genotyping with selective adaptor ligation |
WO2006122401A1 (en) * | 2005-05-16 | 2006-11-23 | Institut De Recherches Cliniques De Montreal/I.R.C.M. | Negative regulation of nk cell functions by eat-2, a sap-related adaptor expressed in innate immune cells |
US8486629B2 (en) | 2005-06-01 | 2013-07-16 | Bioarray Solutions, Ltd. | Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation |
WO2007056394A2 (en) * | 2005-11-08 | 2007-05-18 | The Trustees Of Columbia University In The City Of New York | Genetic markers of true low birth weight |
US7623624B2 (en) * | 2005-11-22 | 2009-11-24 | Illumina, Inc. | Method and apparatus for labeling using optical identification elements characterized by X-ray diffraction |
US11306351B2 (en) | 2005-12-21 | 2022-04-19 | Affymetrix, Inc. | Methods for genotyping |
EP2004849A2 (en) * | 2006-03-10 | 2008-12-24 | Council of Scientific & Industrial Research | A method for the screening of bacterial isolates |
US7830575B2 (en) * | 2006-04-10 | 2010-11-09 | Illumina, Inc. | Optical scanner with improved scan time |
AU2007237909A1 (en) * | 2006-04-19 | 2007-10-25 | Applied Biosystems, Llc. | Reagents, methods, and libraries for gel-free bead-based sequencing |
US20080003667A1 (en) * | 2006-05-19 | 2008-01-03 | Affymetrix, Inc. | Consumable elements for use with fluid processing and detection systems |
NZ577870A (en) | 2006-12-21 | 2014-01-31 | Agriculture Victoria Serv Pty | Artificial selection method and reagents |
EP2152915A2 (en) * | 2007-05-14 | 2010-02-17 | Insight Genetics, Inc. | Methods of screening nucleic acids for single nucleotide variations |
US20080293589A1 (en) * | 2007-05-24 | 2008-11-27 | Affymetrix, Inc. | Multiplex locus specific amplification |
WO2008144827A1 (en) | 2007-05-31 | 2008-12-04 | The University Of Queensland | Diagnostic markers for ankylosing spondylitis and uses thereof |
US9388457B2 (en) | 2007-09-14 | 2016-07-12 | Affymetrix, Inc. | Locus specific amplification using array probes |
EP2212434A1 (en) * | 2007-10-01 | 2010-08-04 | Applied Biosystems Inc. | Chase ligation sequencing |
US20090233809A1 (en) * | 2008-03-04 | 2009-09-17 | Affymetrix, Inc. | Resequencing methods for identification of sequence variants |
US9074244B2 (en) * | 2008-03-11 | 2015-07-07 | Affymetrix, Inc. | Array-based translocation and rearrangement assays |
DK2644707T3 (en) | 2008-04-30 | 2015-06-29 | Integrated Dna Tech Inc | RNase-H-based assays using modified RNA monomers. |
US8911948B2 (en) * | 2008-04-30 | 2014-12-16 | Integrated Dna Technologies, Inc. | RNase H-based assays utilizing modified RNA monomers |
WO2009137912A1 (en) * | 2008-05-15 | 2009-11-19 | Topigen Pharmaceuticals Inc. | Oligonucleotides for treating inflammation and neoplastic cell proliferation |
US9523701B2 (en) | 2009-07-29 | 2016-12-20 | Dynex Technologies, Inc. | Sample plate systems and methods |
GB0913258D0 (en) | 2009-07-29 | 2009-09-02 | Dynex Technologies Inc | Reagent dispenser |
AU2012236896A1 (en) | 2011-03-25 | 2013-05-16 | Integrated Dna Technologies, Inc. | RNase H-based assays utilizing modified RNA monomers |
WO2014140167A1 (en) | 2013-03-14 | 2014-09-18 | Dsm Ip Assets B.V. | Cell wall deconstruction enzymes of malbranchea cinnamomea and uses thereof |
WO2014140165A1 (en) | 2013-03-14 | 2014-09-18 | Dsm Ip Assets B.V. | Cell wall deconstruction enzymes of paecilomyces byssochlamydoides and uses thereof |
JP2019517252A (en) | 2016-05-31 | 2019-06-24 | クアンタポール, インコーポレイテッド | Two-color nanopore sequencing |
CN109804087A (en) | 2016-08-19 | 2019-05-24 | 昆塔波尔公司 | Using quencher based on optical nano-pore sequencing |
WO2018209398A1 (en) | 2017-05-17 | 2018-11-22 | Microbio Pty Ltd | Biomarkers and uses thereof |
WO2019200326A1 (en) | 2018-04-13 | 2019-10-17 | Rarecyte, Inc. | Kits for labeling of biomarkers and methods of using the same |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4613566A (en) * | 1984-01-23 | 1986-09-23 | President And Fellows Of Harvard College | Hybridization assay and kit therefor |
US4689295A (en) * | 1983-01-20 | 1987-08-25 | Integrated Genetics, Inc. | Test for Salmonella |
US4710465A (en) * | 1984-04-19 | 1987-12-01 | Yale University | Junction-fragment DNA probes and probe clusters |
US4849332A (en) * | 1987-05-26 | 1989-07-18 | Life Technologies, Inc. | Human papillomavirus 35 nucleic acid hybridization probes and methods for employing the same |
US4868104A (en) * | 1985-09-06 | 1989-09-19 | Syntex (U.S.A.) Inc. | Homogeneous assay for specific polynucleotides |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4865968A (en) * | 1985-04-01 | 1989-09-12 | The Salk Institute For Biological Studies | DNA sequencing |
GB8810400D0 (en) * | 1988-05-03 | 1988-06-08 | Southern E | Analysing polynucleotide sequences |
-
1988
- 1988-10-24 US US07/261,702 patent/US5002867A/en not_active Expired - Fee Related
-
1989
- 1989-10-23 WO PCT/US1989/004741 patent/WO1990004652A1/en not_active Application Discontinuation
- 1989-10-23 EP EP19890912884 patent/EP0439550A4/en not_active Withdrawn
- 1989-10-23 JP JP2500627A patent/JPH04501362A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4689295A (en) * | 1983-01-20 | 1987-08-25 | Integrated Genetics, Inc. | Test for Salmonella |
US4613566A (en) * | 1984-01-23 | 1986-09-23 | President And Fellows Of Harvard College | Hybridization assay and kit therefor |
US4710465A (en) * | 1984-04-19 | 1987-12-01 | Yale University | Junction-fragment DNA probes and probe clusters |
US4868104A (en) * | 1985-09-06 | 1989-09-19 | Syntex (U.S.A.) Inc. | Homogeneous assay for specific polynucleotides |
US4849332A (en) * | 1987-05-26 | 1989-07-18 | Life Technologies, Inc. | Human papillomavirus 35 nucleic acid hybridization probes and methods for employing the same |
Non-Patent Citations (1)
Title |
---|
See also references of EP0439550A4 * |
Cited By (106)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5525464A (en) * | 1987-04-01 | 1996-06-11 | Hyseq, Inc. | Method of sequencing by hybridization of oligonucleotide probes |
US6451996B1 (en) | 1987-04-01 | 2002-09-17 | Callida Genomics, Inc. | Method of sequencing of genomes by hybridization of oligonucleotide probes |
US6270961B1 (en) | 1987-04-01 | 2001-08-07 | Hyseq, Inc. | Methods and apparatus for DNA sequencing and DNA identification |
US6018041A (en) * | 1987-04-01 | 2000-01-25 | Hyseq, Inc. | Method of sequencing genomes by hybridization of oligonucleotide probes |
US5695940A (en) * | 1987-04-01 | 1997-12-09 | Hyseq, Inc. | Method of sequencing by hybridization of oligonucleotide probes |
US5667972A (en) * | 1987-04-01 | 1997-09-16 | Hyseg, Inc. | Method of sequencing of genoms by hybridization of oligonucleotide probes |
EP0392546A3 (en) * | 1989-04-14 | 1991-09-11 | Ro Institut Za Molekularnu Genetiku I Geneticko Inzenjerstvo | Process for determination of a complete or a partial contents of very short sequences in the samples of nucleic acids connected to the discrete particles of microscopic size by hybridization with oligonucleotide probes |
EP0392546A2 (en) * | 1989-04-14 | 1990-10-17 | Ro Institut Za Molekularnu Genetiku I Geneticko Inzenjerstvo | Process for determination of a complete or a partial contents of very short sequences in the samples of nucleic acids connected to the discrete particles of microscopic size by hybridization with oligonucleotide probes |
US6225625B1 (en) | 1989-06-07 | 2001-05-01 | Affymetrix, Inc. | Signal detection methods and apparatus |
US5871928A (en) * | 1989-06-07 | 1999-02-16 | Fodor; Stephen P. A. | Methods for nucleic acid analysis |
US6197506B1 (en) | 1989-06-07 | 2001-03-06 | Affymetrix, Inc. | Method of detecting nucleic acids |
US6600031B1 (en) * | 1989-06-07 | 2003-07-29 | Affymetrix, Inc. | Methods of making nucleic acid or oligonucleotide arrays |
US5925525A (en) * | 1989-06-07 | 1999-07-20 | Affymetrix, Inc. | Method of identifying nucleotide differences |
US5889165A (en) * | 1989-06-07 | 1999-03-30 | Affymetrix, Inc. | Photolabile nucleoside protecting groups |
US5489678A (en) * | 1989-06-07 | 1996-02-06 | Affymax Technologies N.V. | Photolabile nucleoside and peptide protecting groups |
US6124102A (en) * | 1989-06-07 | 2000-09-26 | Affymetrix, Inc. | Methods for determining receptor-ligand binding using probe arrays |
US5800992A (en) * | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
US5143854A (en) * | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US5744101A (en) * | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
US5744305A (en) * | 1989-06-07 | 1998-04-28 | Affymetrix, Inc. | Arrays of materials attached to a substrate |
FR2667325A1 (en) * | 1990-09-28 | 1992-04-03 | Bertin & Cie | METHOD FOR RAPID SEQUENCING OF LINEAR AND ORDERED BIOLOGICAL SEQUENCES. |
EP0478450A1 (en) * | 1990-09-28 | 1992-04-01 | Bertin & Cie | Method of rapid sequencing of linear and ordered biological sequences |
WO1992006217A1 (en) * | 1990-09-28 | 1992-04-16 | Bertin & Cie | Method for fast sequencing of linear and ordered biological sequences |
US7056666B2 (en) | 1990-12-06 | 2006-06-06 | Affymetrix, Inc. | Analysis of surface immobilized polymers utilizing microfluorescence detection |
WO1992010092A1 (en) * | 1990-12-06 | 1992-06-25 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
EP0535242A1 (en) * | 1991-03-18 | 1993-04-07 | Institut Molekulyarnoi Biologii Imeni V.A. Engelgardta Akademii Nauk Sssr | Method and device for determining nucleotide sequence of dna |
EP0535242A4 (en) * | 1991-03-18 | 1993-08-11 | Institut Molekulyarnoi Biologii Imeni V.A. Engelgardta Akademii Nauk Sssr | Method and device for determining nucleotide sequence of dna |
US7736906B2 (en) | 1991-11-22 | 2010-06-15 | Affymetrix, Inc. | Combinatorial strategies for polymer synthesis |
US6136269A (en) * | 1991-11-22 | 2000-10-24 | Affymetrix, Inc. | Combinatorial kit for polymer synthesis |
US7691330B1 (en) | 1991-11-22 | 2010-04-06 | Affymetrix, Inc. | Combinatorial strategies for polymer synthesis |
EP1382386A3 (en) * | 1992-02-19 | 2004-12-01 | The Public Health Research Institute Of The City Of New York, Inc. | Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids |
EP1382386A2 (en) * | 1992-02-19 | 2004-01-21 | The Public Health Research Institute Of The City Of New York, Inc. | Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids |
US6153379A (en) * | 1993-06-22 | 2000-11-28 | Baylor College Of Medicine | Parallel primer extension approach to nucleic acid sequence analysis |
US7001722B1 (en) | 1993-06-22 | 2006-02-21 | Baylor College Of Medicine | Parallel primer extension approach to nucleic acid sequence analysis |
US6291186B1 (en) | 1993-07-23 | 2001-09-18 | Lewis S. Gruber | Method for screening for unknown organisms |
US6107031A (en) * | 1993-07-23 | 2000-08-22 | Hyseq, Inc. | Method for screening for unknown organisms |
US7794943B2 (en) | 1993-10-26 | 2010-09-14 | Affymetrix, Inc. | Modified nucleic acid probes |
US6156501A (en) * | 1993-10-26 | 2000-12-05 | Affymetrix, Inc. | Arrays of modified nucleic acid probes and methods of use |
US7375198B2 (en) | 1993-10-26 | 2008-05-20 | Affymetrix, Inc. | Modified nucleic acid probes |
US6025136A (en) * | 1994-12-09 | 2000-02-15 | Hyseq, Inc. | Methods and apparatus for DNA sequencing and DNA identification |
EP0731173A2 (en) * | 1995-03-10 | 1996-09-11 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin | Method for the direct detection of a few oligonucleotides |
EP0731173A3 (en) * | 1995-03-10 | 2000-02-23 | Evotec BioSystems AG | Method for the direct detection of a few oligonucleotides |
US6376183B1 (en) | 1995-06-28 | 2002-04-23 | Amersham Pharmacia Biotech Uk Limited | Primer walking cycle sequencing |
WO1997001645A1 (en) * | 1995-06-28 | 1997-01-16 | Amersham Life Science | Primer walking cycle sequencing |
US6043059A (en) * | 1995-06-28 | 2000-03-28 | Amersham Pharmacia Biotech Uk | Primer walking cycle sequencing using presynthesized primers containing nucleotide analogs |
WO1997005276A3 (en) * | 1995-07-25 | 1997-03-06 | Deutsches Krebsforsch | Method of sequencing by oligomer hybridisation |
WO1997005276A2 (en) * | 1995-07-25 | 1997-02-13 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Method of sequencing by oligomer hybridisation |
US6562566B1 (en) | 1995-07-25 | 2003-05-13 | Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts | Method of sequencing by oligomer hybridization |
WO1997010365A1 (en) * | 1995-09-15 | 1997-03-20 | Affymax Technologies N.V. | Expression monitoring by hybridization to high density oligonucleotide arrays |
US6040138A (en) * | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
US6965020B2 (en) | 1996-01-23 | 2005-11-15 | Affymetrix, Inc. | Nucleic acid labeling compounds |
US7282327B2 (en) | 1996-01-23 | 2007-10-16 | Affymetrix, Inc. | Nucleic acid labeling compounds |
US6864059B2 (en) | 1996-01-23 | 2005-03-08 | Affymetrix, Inc. | Biotin containing C-glycoside nucleic acid labeling compounds |
US7423143B2 (en) | 1996-01-23 | 2008-09-09 | Affymetrix. Inc. | Nucleic acid labeling compounds |
US7291463B2 (en) | 1996-01-23 | 2007-11-06 | Affymetrix, Inc. | Nucleic acid labeling compounds |
US6297006B1 (en) | 1997-01-16 | 2001-10-02 | Hyseq, Inc. | Methods for sequencing repetitive sequences and for determining the order of sequence subfragments |
US6309824B1 (en) | 1997-01-16 | 2001-10-30 | Hyseq, Inc. | Methods for analyzing a target nucleic acid using immobilized heterogeneous mixtures of oligonucleotide probes |
US6383742B1 (en) | 1997-01-16 | 2002-05-07 | Radoje T. Drmanac | Three dimensional arrays for detection or quantification of nucleic acid species |
US6355419B1 (en) | 1998-04-27 | 2002-03-12 | Hyseq, Inc. | Preparation of pools of nucleic acids based on representation in a sample |
US7491818B2 (en) | 1998-07-31 | 2009-02-17 | Affymetrix, Inc. | Nucleic acid labeling compounds |
US7179905B2 (en) | 1998-07-31 | 2007-02-20 | Affymetrix, Inc. | Nucleic acid labeling compounds |
US6596856B2 (en) | 1998-07-31 | 2003-07-22 | Affymetrix, Inc. | Nucleic acid labeling compounds |
US6844433B2 (en) | 1998-07-31 | 2005-01-18 | Affymetrix, Inc. | Nucleic acid labeling compounds |
US7071324B2 (en) | 1998-10-13 | 2006-07-04 | Brown University Research Foundation | Systems and methods for sequencing by hybridization |
US7034143B1 (en) * | 1998-10-13 | 2006-04-25 | Brown University Research Foundation | Systems and methods for sequencing by hybridization |
US6689563B2 (en) | 1998-10-13 | 2004-02-10 | Brown University Research Foundation | System and methods for sequencing by hybridization |
US9926521B2 (en) | 2000-06-27 | 2018-03-27 | Fluidigm Corporation | Microfluidic particle-analysis systems |
US7468243B2 (en) | 2001-03-12 | 2008-12-23 | Affymetrix, Inc. | 2-aminopyrimidin-4-one nucleic acid labeling compounds |
US8026057B2 (en) | 2001-03-12 | 2011-09-27 | Affymetrix, Inc. | Nucleic acid labeling compounds |
US8497064B2 (en) | 2001-03-12 | 2013-07-30 | Affymetrix, Inc. | Nucleic acid labelling compounds |
US8076072B2 (en) | 2001-03-12 | 2011-12-13 | Affymetrix, Inc. | Nucleic acid labeling compounds |
US8486636B2 (en) | 2001-04-06 | 2013-07-16 | California Institute Of Technology | Nucleic acid amplification using microfluidic devices |
US8936764B2 (en) | 2001-04-06 | 2015-01-20 | California Institute Of Technology | Nucleic acid amplification using microfluidic devices |
US7833708B2 (en) | 2001-04-06 | 2010-11-16 | California Institute Of Technology | Nucleic acid amplification using microfluidic devices |
US8658418B2 (en) | 2002-04-01 | 2014-02-25 | Fluidigm Corporation | Microfluidic particle-analysis systems |
US9714443B2 (en) | 2002-09-25 | 2017-07-25 | California Institute Of Technology | Microfabricated structure having parallel and orthogonal flow channels controlled by row and column multiplexors |
US10940473B2 (en) | 2002-10-02 | 2021-03-09 | California Institute Of Technology | Microfluidic nucleic acid analysis |
US9579650B2 (en) | 2002-10-02 | 2017-02-28 | California Institute Of Technology | Microfluidic nucleic acid analysis |
US10328428B2 (en) | 2002-10-02 | 2019-06-25 | California Institute Of Technology | Apparatus for preparing cDNA libraries from single cells |
WO2005093094A2 (en) * | 2004-03-25 | 2005-10-06 | Genizon Svenska Ab | Methods and means for nucleic acid sequencing |
WO2005093094A3 (en) * | 2004-03-25 | 2005-12-22 | Genizon Svenska Ab | Methods and means for nucleic acid sequencing |
US9217177B2 (en) | 2005-02-01 | 2015-12-22 | Applied Biosystems, Llc | Methods for bead-based sequencing |
US10323277B2 (en) | 2005-02-01 | 2019-06-18 | Applied Biosystems, Llc | Reagents, methods, and libraries for bead-based sequencing |
US9493830B2 (en) | 2005-02-01 | 2016-11-15 | Applied Biosystems, Llc | Reagents, methods, and libraries for bead-based sequencing |
US10793904B2 (en) | 2005-07-20 | 2020-10-06 | Illumina Cambridge Limited | Methods for sequencing a polynucleotide template |
US9765391B2 (en) | 2005-07-20 | 2017-09-19 | Illumina Cambridge Limited | Methods for sequencing a polynucleotide template |
US11542553B2 (en) | 2005-07-20 | 2023-01-03 | Illumina Cambridge Limited | Methods for sequencing a polynucleotide template |
WO2008134867A1 (en) * | 2007-05-04 | 2008-11-13 | Genizon Biosciences Inc. | Methods, kits, and systems for nucleic acid sequencing by hybridization |
US9051609B2 (en) | 2007-10-01 | 2015-06-09 | Nabsys, Inc. | Biopolymer Sequencing By Hybridization of probes to form ternary complexes and variable range alignment |
US8882980B2 (en) | 2008-09-03 | 2014-11-11 | Nabsys, Inc. | Use of longitudinally displaced nanoscale electrodes for voltage sensing of biomolecules and other analytes in fluidic channels |
US8926813B2 (en) | 2008-09-03 | 2015-01-06 | Nabsys, Inc. | Devices and methods for determining the length of biopolymers and distances between probes bound thereto |
US9719980B2 (en) | 2008-09-03 | 2017-08-01 | Nabsys 2.0 Llc | Devices and methods for determining the length of biopolymers and distances between probes bound thereto |
US9650668B2 (en) | 2008-09-03 | 2017-05-16 | Nabsys 2.0 Llc | Use of longitudinally displaced nanoscale electrodes for voltage sensing of biomolecules and other analytes in fluidic channels |
EP2379748A2 (en) * | 2008-12-23 | 2011-10-26 | Illumina, Inc. | Multibase delivery for long reads in sequencing by synthesis protocols |
US8709729B2 (en) | 2008-12-23 | 2014-04-29 | Illumina, Inc. | Method of making an array of nucleic acid colonies |
US8476022B2 (en) | 2008-12-23 | 2013-07-02 | Illumina, Inc. | Method of making an array of nucleic acid colonies |
EP2379748A4 (en) * | 2008-12-23 | 2012-08-29 | Illumina Inc | Multibase delivery for long reads in sequencing by synthesis protocols |
US10167506B2 (en) | 2008-12-23 | 2019-01-01 | Illumina, Inc. | Method of sequencing nucleic acid colonies formed on a patterned surface by re-seeding |
US9416415B2 (en) | 2008-12-23 | 2016-08-16 | Illumina, Inc. | Method of sequencing nucleic acid colonies formed on a surface by re-seeding |
US9005929B2 (en) | 2008-12-23 | 2015-04-14 | Illumina, Inc. | Multibase delivery for long reads in sequencing by synthesis protocols |
US9434981B2 (en) | 2010-09-27 | 2016-09-06 | Nabsys 2.0 Llc | Assay methods using nicking endonucleases |
US8859201B2 (en) | 2010-11-16 | 2014-10-14 | Nabsys, Inc. | Methods for sequencing a biomolecule by detecting relative positions of hybridized probes |
US9702003B2 (en) | 2010-11-16 | 2017-07-11 | Nabsys 2.0 Llc | Methods for sequencing a biomolecule by detecting relative positions of hybridized probes |
US11274341B2 (en) | 2011-02-11 | 2022-03-15 | NABsys, 2.0 LLC | Assay methods using DNA binding proteins |
US9914966B1 (en) | 2012-12-20 | 2018-03-13 | Nabsys 2.0 Llc | Apparatus and methods for analysis of biomolecules using high frequency alternating current excitation |
US10294516B2 (en) | 2013-01-18 | 2019-05-21 | Nabsys 2.0 Llc | Enhanced probe binding |
Also Published As
Publication number | Publication date |
---|---|
EP0439550A4 (en) | 1991-09-25 |
JPH04501362A (en) | 1992-03-12 |
EP0439550A1 (en) | 1991-08-07 |
US5002867A (en) | 1991-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0439550A4 (en) | Dna sequencing by multiple mixed oligonucleotide probes | |
Hare et al. | Assignment of the non-exchangeable proton resonances of d (CGCGAATTCGCG) using two-dimensional nuclear magnetic resonance methods | |
US5583211A (en) | Surface activated organic polymers useful for location - specific attachment of nucleic acids, peptides, proteins and oligosaccharides | |
CA1237685A (en) | Process for amplifying nucleic acid sequences | |
US5750341A (en) | DNA sequencing by parallel oligonucleotide extensions | |
EP0705349B1 (en) | Parallel primer extension approach to nucleic acid sequence analysis | |
US5571677A (en) | Convergent synthesis of branched and multiply connected macromomolecular structures | |
IL153473A (en) | Method for detecting errors in a sequencing reaction | |
US6153379A (en) | Parallel primer extension approach to nucleic acid sequence analysis | |
WO1991006678A1 (en) | Dna sequencing | |
WO1991000288A1 (en) | Hydrophobic nucleic acid probe | |
CN114657232A (en) | Universal blocking reagent for improving target capture efficiency and application thereof | |
US5738993A (en) | Oligonucleotide and method for analyzing base sequence of nucleic acid | |
EP0721458B1 (en) | Biopolymer synthesis utilizing surface activated, organic polymers | |
EP0322677B1 (en) | Carrier for DNA-hybridization | |
JP3626782B2 (en) | Oligonucleotide and nucleic acid sequence analysis method | |
Jiang et al. | A new method of preparing fiber-optic DNA biosensor and its array for gene detection | |
SELIGER et al. | Simultaneous synthesis of multiple oligonucleotides using nucleoside-H-phosphonate intermediates | |
JPH01500003A (en) | Polynucleotide probes on solid supports with photolabile binding | |
JP2653164B2 (en) | Species determining oligonucleotide of Vibrio angularum and its use | |
JP2001515614A (en) | Molecular computer | |
EP0206411A2 (en) | Reverse phase chromatography in oligonucleotide sequencing | |
JPH10262675A (en) | Analysis of base sequence of oligonucleotide and nucleic acid | |
CA2284481A1 (en) | Method of producing a subtraction library | |
JPH02174700A (en) | Determination of dna base sequence and device therefor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1989912884 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1989912884 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1989912884 Country of ref document: EP |